[
    {
        "pmid": "40791280",
        "title": "Penicillium-Derived Inhibitors of <i>Plasmodium falciparum</i> Lactate Dehydrogenase (PfLDH): A Computational Approach for Novel Antimalarial Therapy Development.",
        "abstract": "Malaria remains major global health challenge necessitating discovery novel therapeutic agents study investigates secondary metabolite iPenicilliumi spp potential inhibitor iPlasmodium falciparumi lactate dehydrogenase PfLDH critical enzyme parasites glycolytic pathway curated library iPenicilliumiderived compound underwent druglikeness toxicity screening resulting identification 42 viable candidates Molecular docking simulation revealed three promising compoundsPenicilactone B Penicillimide Penicillisocoumarin Awith binding affinity exceeding positive controls NADH pyruvate Among these Penicilactone B exhibited strongest binding affinity 871 kcalmol lowest inhibitory constant 41477 nM Molecular dynamic simulation confirmed stability compound within PfLDH binding pocket 200ns trajectory Penicilactone B demonstrating stable interactions Offtarget prediction suggested minimal interaction human lactate dehydrogenase indicating potentially favorable safety profile Penicilactone B emerged promising candidate due molecular stability efficient binding favorable solvent interactions Penicillisocoumarin also showed potential supported pharmacokinetic property safety indicators finding highlight potential penicilliumderived secondary metabolite promising source novel antimalarial therapy targeting PfLDH Future research focus experimental validation pharmacokinetic optimization efficacy testing diverse iPlasmodiumi strains",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791280/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40764298",
        "title": "Microhaplotype deep sequencing assays to capture Plasmodium vivax infection lineages.",
        "abstract": "Plasmodium vivax elimination challenged dormant liver stage hypnozoites reactivate month initial infection resulting relapses Relapsing infection confound antimalarial clinical efficacy trial due inability distinguish recurrence arising bloodstage treatment failure recrudescence reinfection relapse Genetic relatedness paired parasite isolates measured identitybydescent IBD provide important information whether individual single multiple mosquito inoculations thus informing recurrence origin developed highthroughput amplicon sequencing assay comprising 93 multiSNP microhaplotype marker determine IBD P vivax clinical isolates assay evaluated 745 global infections including 128 infection pair randomized controlled trial RCT ClinicalTrialsgov NCT01680406 Simulations demonstrate low error pairwise IBD estimation panel RMSE  012 IBDbased network illustrate strong clustering geography IBD analysis RCT demonstrates lower frequency suspected relapse recrudescence patient treated primaquine compared without primaquine impact greater paired chloroquine artemetherlumefantrine result demonstrate potential derive new information P vivax treatment transmission using IBD generated amplicon sequencing data improved timetoevent models",
        "mesh_terms": [
            "Plasmodium vivax",
            "Malaria, Vivax",
            "Humans",
            "High-Throughput Nucleotide Sequencing",
            "Antimalarials",
            "Haplotypes",
            "Polymorphism, Single Nucleotide",
            "Primaquine",
            "Chloroquine",
            "Recurrence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764298/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40760068",
        "title": "Unraveling global malaria incidence and mortality using machine learning and artificial intelligence-driven spatial analysis.",
        "abstract": "Malaria remains significant global health concern contributing substantial morbidity mortality worldwide inform effort aimed alleviating global malaria burden study utilized spatial analysis advanced machine learning ML explainable AI XAI identify highrisk areas uncover key determinants predict disease outcomes establish causal relationships study analyzed data 106 country 2000 2022 sourced World Health Organization World Bank UNICEF highperformance ML classifier XGBoost combined XAI causal AI CAI technique employed evaluate malaria incidence mortality Spatial autocorrelation analyses GetisOrd Gi Morans I utilized detect significant geographical cluster hotspot malaria 2022 malaria case reached 25175 million peak malariarelated fatality occurred 2020 totaling 99554 Nigeria recorded highest malaria incidence 133299 million followed Democratic Republic Congo 62316 million India 31983 million South Sudan 149753 Zambia 143546 Central African Republic 124801 exhibited highest malaria mortality rates Highincidence cluster observed Benin Burkina Faso Ghana substantial mortality cluster Benin Central African Republic Liberia XGBoost model demonstrated best predictive performance malaria incidence mortality RMSE  063 r²  093 adjusted r²  092 MAE  046 XAI CAI methodology identified key determinant malaria access basic sanitation electricity availability population growth under5 mortality rate integrated framework driven machine learning artificial intelligence offer actionable insight identifying determinant hotspot malaria spatial analysis study advocate incorporation AIdriven spatial model national malaria surveillance system facilitate evidencebased targeted interventions",
        "mesh_terms": [
            "Humans",
            "Malaria",
            "Incidence",
            "Machine Learning",
            "Spatial Analysis",
            "Global Health",
            "Artificial Intelligence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40760068/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40689184",
        "title": "<i>In vitro</i> and <i>in silico</i> investigations of Propolis-derived phytochemicals as potential inhibitors of <i>Plasmodium falciparum</i>.",
        "abstract": "Malaria continues pose global health challenge exacerbated emergence drugresistant strain iPlasmodium falciparumi study aimed evaluate antiiPlasmodiumi potential Propolis extract collected various Iranian region characterize molecular interaction bioactive phytochemical iP falciparumi lactate dehydrogenase PfLDH key enzyme parasite glycolysis antiiPlasmodiumi activity ethanolextracted Propolis assessed iP falciparumi NF54 using SYBR Green fluorescence assay Gas chromatographymass spectrometry GCMS analysis identified major phytochemical active extract Molecular docking 100ns molecular dynamic MD simulation performed evaluate binding affinity stability selected compound tectochrysin galangin PfLDH holo Protein Data Bank PDB ID 1LDG apo PDB ID 2X8L forms Propolis collected Kermanshah city exhibited highest antiiPlasmodiumi activity ICsub50sub  669 ± 144 μgmL GCMS analysis identified tectochrysin galangin major constituents Molecular docking revealed strong binding affinity tectochrysin 78 kcalmol galangin 75 kcalmol PfLDH surpassing binding energy standard antimalarial drug chloroquine quinine MD simulation confirmed stability tectochrysin galangin within PfLDH active sites favorable root mean square deviation root mean square fluctuation gyration solventaccessible surface area molecular surface area polar surface area profiles indicating persistent stable proteinligand interaction throughout simulation finding support promising antiiPlasmodiumi potential Propolisderived compounds particularly tectochrysin galangin novel PfLDH inhibitors potential applicability transdisciplinary antiparasitic therapy across human veterinary medicine warrant iin vivoi validation clinical investigations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40689184/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40687925",
        "title": "Infectious disease research in forcibly displaced populations: A systematic review in low- and middle-income host countries.",
        "abstract": "Infectious disease research essential disease prevention management within refugee camp informal settlements objective study identify characteristic existing infectious disease research setting assess stated research challenges ethical considerations studied intervention within studies systematic review forty primary study focused infectious disease research conducted among displaced populations Included study published English 1995 2023 Three database searched PubMed Embase Web Science review registered PROSPERO CRD42023461567 risk bias study assessed using Mixed Methods Appraisal Tool 85  study ini  34 researched intervention infectious disease prevention control 70  study ini  28 randomized controlled trials 75  study located Bangladesh ini  15 Pakistan ini  15 40  study focused diarrheal disease ini  16 28  malaria ini  11 Common identified research challenge included population mobility limited external validity low recruitment study included community initial study conception investigated research impact community Community involvement often community health worker 45  18 study studied resourcebased intervention 20  explicitly noted intervention unsustainable guideline conducting research displaced setting exist gap utilization identified disconnect displaced individual reside research conducted well prioritization particular infectious diseases Researchers identified numerous challenge conducting research settings though community rarely involved research Contextspecific consideration community involvement vital research displaced communities Wellcome Trust Contract Number C010656",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40687925/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40686689",
        "title": "Evaluation of health impacts of a disability-inclusive graduation programme among ultra-poor people with disabilities in Uganda: secondary analysis of a cluster randomized trial.",
        "abstract": "People disability experience significant health inequality barrier healthcare access globally poverty alleviation intervention show promise improving health outcomes evidence specifically people disability remains limited study evaluated effectiveness disabilityinclusive graduation DIG programme health outcome among ultrapoor people disability Uganda conducted twoarm parallel clusterrandomized controlled trial four district Northern Uganda Clusters randomly assigned either DIG intervention 96 clusters control group 89 clusters analysis focused household people disabilities identified Washington Group Short Set question verified BRAC programme managers Households treatment cluster received 18 month DIG intervention December 2020 June 2022 combining asset transfers cash support skill training financial inclusion activities disabilityspecific service including rehabilitation assistive devices primary outcome experience illnessinjury past 3 months assessed first followup immediately postintervention second followup about 16 month postintervention secondary outcome including unmet health needs mental health status unmet assistive product needs healthcare expenditure Effects estimated using linear mixedeffects regression generalized estimating equations reporting minimallyadjusted fullyadjusted mean difference FAMD odds ratio FAOR 95 CIs trial registered RIDIE RIDIESTUDYID626008898983a ISRCTN ISRCTN78592382 baseline 691 participant 370 intervention 321 control included DIG intervention significantly impact overall illnessinjury prevalence either first followup 4118 v 4586 FAOR 084 95 CI 058122 second followup 5565 v 5398 FAOR 107 95 CI 074156 However intervention demonstrated progressively strengthening effect reducing unmet health needs marginal improvement immediately postintervention FAOR 056 95 CI 031102 p  006 significant reduction 16 month postintervention FAOR 04 95 CI 022071 p  0002 Notably intervention produced temporal potential shift disease patterns malaria showing contrasting trend followup periods Sexdifferentiated effect emerged second followup female intervention group experiencing fewer injury FAOR interaction 017 95 CI 004074 p  002 painrelated condition compared male FAOR interaction 243 95 CI 105559 p  004 though subgroup finding require replication future studies significant difference observed mental health outcome health expenditure first randomized evaluation disabilityinclusive graduation programme demonstrates economic empowerment alone may reduce overall illness prevalence among people disabilities progressively improve healthcare access time temporal evolution effect emerging sexdifferentiated impact highlight need sustained support gendersensitive approach future disabilityinclusive poverty reduction programmes additional healthspecific component achieve broader improvement health outcomes PENDA funded UK Foreign Commonwealth Development Office",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40686689/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40663613",
        "title": "A population genetic analysis of the nematode <i>Strongyloides stercoralis</i> in Asia shows that human infection is not a zoonosis from dogs.",
        "abstract": "Gut nematode worm important parasite people animals parasitic nematode iStrongyloides stercoralisi infects estimated 600 million people worldwide one soiltransmitted helminthiases WHOdefined neglected tropical disease long suggested human iS stercoralisi infection may zoonosis dogs investigated whole genome sequence analysis iS stercoralisi sympatric human dog population Asia find human dogderived iS stercoralisi genetically distinct nuclear genomes also find evidence rare crossinfection Analysis iS stercoralisi mitochondrial genome reveals evidence historical introgression human dogderived parasites Based data suggest iS stercoralisi originally parasite canids began infect human people domesticated dogs since human dogderived parasite differentiated become separate species",
        "mesh_terms": [
            "Animals",
            "Dogs",
            "Strongyloides stercoralis",
            "Humans",
            "Zoonoses",
            "Strongyloidiasis",
            "Asia",
            "Dog Diseases",
            "Genetics, Population",
            "Phylogeny",
            "Genome, Mitochondrial"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40663613/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40335470",
        "title": "Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019.",
        "abstract": "Chronic care manages longterm progressive conditions acute care address shortterm conditions Chronic condition increasingly strain health systems often unprepared demands study examines burden condition requiring acute versus chronic care including sequelae Conditions sequela Global Burden Diseases Study 2019 classified acute chronic care categories Data analysed age sex sociodemographic index presenting total number contribution burden metric DisabilityAdjusted Life Years DALYs Years Lived Disability YLD Years Life Lost YLL Approximately 68 DALYs attributed chronic care 27 due acute care Chronic care need increased age representing 86 YLDs 71 YLLs accounting 93 YLDs sequelae finding highlight chronic care need far exceed acute care need globally necessitating health system adapt accordingly",
        "mesh_terms": [
            "Humans",
            "Chronic Disease",
            "Female",
            "Male",
            "Global Burden of Disease",
            "Middle Aged",
            "Aged",
            "Adult",
            "Disability-Adjusted Life Years",
            "Young Adult",
            "Aged, 80 and over",
            "Health Services Needs and Demand",
            "Adolescent",
            "Acute Disease",
            "Persons with Disabilities",
            "Child",
            "Child, Preschool",
            "Infant",
            "Cost of Illness"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40335470/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40279976",
        "title": "Involution-based efficient autoencoder for denoising histopathological images with enhanced hybrid feature extraction.",
        "abstract": "Noise histopathology image hardware limitations preparation artifacts environmental factor complicates disease analysis increase risks growing workload complexity histopathology images developing efficient precise histopathology image analysis method essential However many denoising model struggle extract spatial feature computationally expensive primarily due limited capacity convolution capture visual pattern across spatial locations tend occupy largest share computational costs histopathology many spatial features anomaly microorganisms located sparsely across image crucial final diagnosis many denoising process often either blur introduce artifacts study propose lightweight autoencoder 4311 kilobytes denoising histopathology image fusing single involution layer within small convolution model resulting better denoising performance hybrid model channelspecific locationspecific feature extraction capabilities Building upon idea shallow autoencoder model result much lower memory compute overhead requirements also avoiding generation artifacts Malaria Blood Smear CRC datasets SSIM Loss PeakSignaltoNoiseRatio used performance evaluation lower SSIM Loss 0058 034 denoising image added Gaussian noise 03 proposed autoencoder low weight parameter 11037 81630000 floating point operation FLOPs 20 time less computationally expensive Xception secondbest performing model establishing efficient denoising autoencoder histopathology images",
        "mesh_terms": [
            "Humans",
            "Image Processing, Computer-Assisted",
            "Signal-To-Noise Ratio",
            "Algorithms",
            "Artifacts",
            "Autoencoder"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40279976/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40251382",
        "title": "Fitness compatibility and dengue virus Inhibition in a Bangladeshi strain of Aedes aegypti infected with the Wolbachia strain wAlbB.",
        "abstract": "Dengue case Bangladesh surged recent years existing insecticidebased control program challenged issue insufficient household coverage high level insecticide resistance primary dengue virus DENV vector Aedes aegypti sustainable effective alternative could implementation Wolbachiamediated disease management strategy Hence created characterised Wolbachiainfected Ae aegypti strain Dhaka wildtype genetic background compared reproductive compatibility maternal inheritance fitness virusblocking ability parental strain Dhaka wildtype wAlbB2F4 new Ae aegypti strain wAlbB2Dhaka demonstrated complete cytoplasmic incompatibility wildtype complete maternal transmission retaining level pyrethroid resistance Dhaka wildtype significant fitness cost detected laboratory comparison Compared wildtype wAlbB2Dhaka mosquito demonstrated significantly reduced genome copy DENV body 444 p  00034 twofold reduction dissemination leg wing 476 p  00001  13fold reduction DENV saliva expectorates proxy transmission potential 927 p  00001 14 day ingesting dengueinfected blood work indicates wAlbB2Dhaka strain could used Ae aegypti suppression replacement strategy dengue management Bangladesh",
        "mesh_terms": [
            "Animals",
            "Aedes",
            "Wolbachia",
            "Dengue Virus",
            "Bangladesh",
            "Dengue",
            "Mosquito Vectors",
            "Genetic Fitness",
            "Female",
            "Mosquito Control"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40251382/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40183042",
        "title": "Metagenome analysis of viruses associated with <i>Anopheles</i> mosquitoes from Ramu Upazila, Cox's Bazar District, Bangladesh.",
        "abstract": "Bangladesh warm climate landscape favourable proliferation mosquitoes Mosquitoborne pathogen including malaria arthropodborne virus arboviruses remain serious threat public health requiring constant vector control disease surveillance November 2018 April 2019 iAnophelesi mosquito collected three union Ramu Upazila subdistrict Coxs Bazar District Bangladesh mosquito specimen combined pool based date collection household ID sex Metagenome nextgeneration sequencing conducted elucidate diversity virus sequence pool Homologybased taxonomic classification phylogenetic analysis identified broad diversity putative virus 12 known families additional unclassified virus also likely present Analysis male mosquito showed virus likely capable vertically transmitted Moreover many assembled virus sequence share homology phylogenetic affinity segment sequenced iAnophelesi genomes may represent endogenous viral element derived past evolutionary relationship putative virus mosquito hosts",
        "mesh_terms": [
            "Anopheles",
            "Animals",
            "Bangladesh",
            "Phylogeny",
            "Mosquito Vectors",
            "Metagenome",
            "Male",
            "Female",
            "High-Throughput Nucleotide Sequencing"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40183042/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40176855",
        "title": "The Global Fund's Bangladesh program.",
        "abstract": "Global Fund program launched 2002 focus combating HIVAIDS tuberculosis TB malaria date mobilized US 65 billion across 120 countries contributing saving 65 million lives Bangladesh Global Fund played pivotal role expanding treatment coverage enhancing case detection strengthening prevention efforts Despite notable progress significant challenge persist particularly among highrisk population people inject drugs sex workers transgender individuals group face stigma limited access healthcare hinder disease control Additionally drug resistance present growing threat control malaria TB Looking ahead continued support Global Fund critical particularly scaling diagnostic infrastructure promoting communityled interventions enhancing crossborder collaboration effort essential ensuring sustained progress achieving longterm goal eliminating HIV TB malaria Bangladesh Effective coordination among government agencies nongovernmental organizations international donor essential ensure success initiatives",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40176855/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40168517",
        "title": "Health service readiness and quality for sick child care: an effective coverage analysis in eight low- and middle-income countries.",
        "abstract": "child death averted prompt appropriate treatment child illness pneumonia diarrhoea malaria However research suggested increase care seeking necessarily mean quality care received assessed service readiness process quality curative healthcare childhood determined whether child receiving health service sufficient quality across countries linked data household survey including standard Demographic Health Survey Multiple Indicator Cluster Survey data facility survey including Service Provision Assessment Health Facility Assessment Bangladesh Democratic Republic Congo Haiti Kenya Malawi Nepal Senegal Tanzania estimate effective coverage child illness treatment assessed gap service availability coverage lack service readiness missed care opportunities inadequate service process service readiness process quality defined according global standard countryspecific adaptations analysed service readiness quality care effective coverage individual illness combined illness accounting equity dimensions Seven 42 child experienced least one illness integrated management child illness IMCI service available 5885 facilities found 5566 health facility country ready deliver treatment sick children However readinessadjusted contact suggested child healthcare mostly sought facility low readiness score ranging 15 Nepal 460 Malawi Health facility low diagnostics supervision trained personnel capacity manage child illnesses Concerning quality care 5160 procedure clinical encounter line standards Counselling caretaker lowest score treatment component highest process quality score Hospitals higher readiness process quality score compared primary facility private sector were however large gap service readiness significant inadequate service process countries 35 Haiti 79 Bangladesh sick child sought care health facility 7 Nepal 29 Malawi actually receiving appropriate treatment found large inequality care seeking quality care effective coverage across level education poverty place residence large proportion facility meet required capacity provide IMCI services provision health service major quality gaps highlighting need strengthening health service access capacity quality care reach universal child health coverage",
        "mesh_terms": [
            "Humans",
            "Quality of Health Care",
            "Child Health Services",
            "Developing Countries",
            "Child, Preschool",
            "Infant",
            "Health Services Accessibility",
            "Child",
            "Female",
            "Male"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40168517/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40132008",
        "title": "Performance of quantitative point-of-care tests to measure G6PD activity: An individual participant data meta-analysis.",
        "abstract": "Glucose6phosphate dehydrogenase G6PD deficiency main risk factor severe haemolysis following treatment 8aminoquinolines 8AQ World Health Organization recommends G6PD testing prior 8AQbased hypnozoitocidal treatment undertook individual level metaanalysis performance commercially available quantitative pointofcare diagnostics PoCs compared reference spectrophotometry systematic literature search PROSPERO CRD42022330733 identified 595 article 16 27 fulfilled predefined inclusion criterion included analysis plus additional 4 datasets total 12678 paired measurement analyzed 10446 824 STANDARD G6PD Test SD Biosensor RoK SDB 2042 161 CareStart G6PD Biosensor AccessBio USA CSA 150 12 CareStart Biosensor WellsBio RoK CSW 40 03 FINDER Baebies USA FBA pooled sensitivity SDB measuring G6PD activity 30 normal 082 95 confidence interval CI 072089 capillary 093 95 CI 075099 venous blood samples corresponding value measuring 70 G6PD activity 093 95 CI 067099 089 95 CI 073096 respectively pooled specificity SDB high 96 blood sample G6PD activity thresholds Irrespective blood sample threshold applied sensitivity CSA exceed 62 although specificity remained high 30 70 threshold 88 one study CSW FBA included Sensitivities CSW 004 95 CI 001014 081 95 CI 071089 30 70 thresholds respectively venous blood samples Sensitivities FBA 100 95 CI 029100 075 95 CI 019099 30 70 threshold venous blood samples Specificities CSW FBA consistently high 90 thresholds Accuracy SDB higher female 30 cutoff OR 349 p0002 lower malaria patient 70 cutoff OR 059 p  0005 SDB performed better PoCs evidence available performance SDB compared PoCs giving higher confidence utility diagnosing G6PD deficiency",
        "mesh_terms": [
            "Humans",
            "Glucosephosphate Dehydrogenase",
            "Glucosephosphate Dehydrogenase Deficiency",
            "Point-of-Care Testing",
            "Male",
            "Sensitivity and Specificity",
            "Female",
            "Point-of-Care Systems",
            "Adult",
            "Aminoquinolines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40132008/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40120597",
        "title": "Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial.",
        "abstract": "Human papillomavirus HPV vaccine available nearly 20 years However overall coverage girl aged 15 year younger low especially lowresource settings burden cervical cancer highest Increasing access facilitating implementation HPV vaccination contribute cervical cancer elimination efforts generate data different dosing regimen lowresource settings aimed evaluate safety immunogenicity various schedule Escherichia coliexpressed bivalent HPV vaccine 2vHPV compared widely used quadrivalent vaccine randomised controlled openlabel noninferiority phase 3 trial enrolled healthy girl aged 914 year single site Ghana Bangladesh Participants randomly assigned via interactive web response system technology equally five study groups stratified site two dos 2vHPV first baseline second 6 12 24 month later quadrivalent HPV vaccine 4vHPV baseline followed 24 month later 2vHPV two dos 4vHPV given 6 month apart referent tested antigenspecific HPV16 HPV18 binding antibody ELISA baseline 1 month second dose primary objective show immunological noninferiority 2vHPV vaccine schedule referent 1 month second dose perprotocol population noninferiority margin 0·5 lower bound 98·3 CI geometric mean concentration GMC ratio Adverse event serious adverse event evaluated secondary endpoint total vaccinated population study registered ClinicalTrialsgov NCT04508309 completed March 15 Nov 18 2021 1025 girl enrolled received 2vHPV baseline 6 month n205 12 month n206 24 month n204 4vHPV baseline 6 month n205 4vHPV baseline 2vHPV 24 month n205 9699 participant across group included perprotocol analysis 1 month second dose 2vHPV noninferiority shown GMC ratio 1·1 2·4 lower bound 98·3 CI GMC ratio 0·9 1·9 HPV16 1·3 1·7 1·0 1·4 HPV18 exploratory objective assessed 2vHPV immunogenicity one dose finding similar 4vHPV 24 months GMC ratio 24 month 1·1 95 CI 0·91·4 HPV16 1·4 1·11·7 HPV18 frequency adverse event similar across study groups related unsolicited event reported Serious adverse event rare none determined related vaccination Noninferior immune response extended twodose regimen 2vHPV support dosing flexibility 24 months one dose 2vHPV elicited immunogenicity similar one dose 4vHPV singledose efficacy shown supporting singledose use 2vHPV Bill  Melinda Gates Foundation German Federal Ministry Education Research immunological testing funded part National Cancer Institute National Institutes Health Bengali translation abstract see Supplementary Materials section",
        "mesh_terms": [
            "Adolescent",
            "Child",
            "Female",
            "Humans",
            "Antibodies, Viral",
            "Bangladesh",
            "Escherichia coli",
            "Ghana",
            "Immunization Schedule",
            "Immunogenicity, Vaccine",
            "Papillomavirus Infections",
            "Papillomavirus Vaccines",
            "Uterine Cervical Neoplasms"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40120597/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40110804",
        "title": "Current access, availability and use of antibiotics in primary care among key low- and middle-income countries and the policy implications.",
        "abstract": "Antimicrobial resistance AMR pose significant threat particularly low middleincome country LMICs exacerbated inappropriate antibiotic use access quality antibiotic weak antimicrobial stewardship AMS need review current evidence antibiotic use access AMR primary care across key countries narrative review analyzes publication 2018 2024 regarding access availability use appropriate antibiotics study focussing lack access antibiotic primary care However considerable evidence high rate inappropriate antibiotic use including Watch antibiotics typically minor infections across studied country exacerbated patient demand high cost antibiotic number LMICs impact use resulting short course sharing antibiotics contribute AMR alongside use substandard falsified antibiotics Overall limited implementation national action plans insufficient resources knowledge gap affect sustainable development goal provide routine access safe effective appropriate antibiotics clear need focus health policy optimal use essential AWaRe antibiotic primary care setting reduce AMR LMICs",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40110804/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40110615",
        "title": "Understanding the primary healthcare context in rural South and Southeast Asia: a village profiling study.",
        "abstract": "Understanding contextual factor critical success health service planning implementation However contextual data available village level rural South Southeast Asia study addressed gap profiling representative village across seven site Thailand n3 Cambodia Laos Myanmar Bangladesh Key informant survey supplemented information source used collect data 687 village four key indicator literacy rate percentage attended deliveries fully immunised child latrine coverage well access various services Data analysed descriptively Sites varied considerably Five highly diverse ethnoculturally linguistically relied primary health centre village healthmalaria worker main provider primary healthcare generally bypassed severely ill patient urban firstlevel referral hospital private sector facilities 75 village near primary schools educational attainment generally low 70 village site mobile phone coverage availability electricity high ≥65 site bar Myanmar result illustrate similarity difference village region must considered public health research policymaking",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40110615/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40106483",
        "title": "Understanding climate-sensitive diseases in Bangladesh using systematic review and government data repository.",
        "abstract": "Understanding effect climate change health outcome crucial effective policy formulation intervention strategies However Low MiddleIncome Countries like Bangladesh true extent effect remains unexplored due data scarcity study aim assess available evidence climate changerelated health outcome Bangladesh compare actual national occurrences explore challenge related climate change health data first conducted systematic review summarize climatesensitive disease examined existing literature Bangladesh review result compared 28 million sample governments data repository representing reported case climatesensitive disease 20172022 comparison aimed identify discrepancy disease currently occurring Bangladesh related climate change available knowledge existing research Additionally also explored limitation data recorded government data repository available literature Bangladesh report specific climatesensitive diseases including Diarrhea Dengue Cholera Malaria Pneumonia Cardiovascular Diseases Hypertension UrinaryTract Infections Malnutrition also considered studies represents segment total 510 reported climatesensitive disease Bangladesh 143 disease responsible 9066 total occurrences common form disease diarrhea gastroenteritis presumed infectious 2851 pneumonia 1888 anxiety disorders panic disorders generalized anxiety disorder 132 others 1315 Additionally UrinaryTract infection 787 cholera 303 typhoid fever 327 frequently reported climatesensitive diseases also explored several challenge related available data government repository include inadequate collection patients comprehensive sociodemographic information absence unique patient identifier finding underscore urgent need tackle data challenge understanding climatesensitive disease Bangladesh Policies program required prioritize digitalization healthcare system implement unique patient identification number facilitate accurate tracking analysis health data Climate Change including rising temperature extreme weather event like cyclone floods pose significant global health threat 1 World Health Organization estimate climate change already cause least 150000 death annually global level number projected double 2030 Beside impact climate change farreaching leading forced displacement malnutrition increased incidence disease dengue diarrhea pneumonia 2 Additionally climate change established link mental health issues like anxiety depression 3 effect particularly severe Low MiddleIncome Countries LMICs due limited resource inadequate infrastructure coping erratic weather disaster 4 undertook comprehensive mixedmethod study incorporating systematic review existing study conducted Bangladesh along analysis government data repository detailed description component presented below",
        "mesh_terms": [
            "Bangladesh",
            "Humans",
            "Climate Change",
            "Diarrhea",
            "Government"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40106483/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40017943",
        "title": "Catastrophic expenditure associated with childhood hospitalisation for acute illness in Kenya and Uganda: a cross-sectional study.",
        "abstract": "Childhood illness hospitalisation result direct indirect cost family before admission aimed estimate catastrophic expenditure hospitalisation child acute illness prespecified crosssectional substudy nested within two prospective studies Participants recruited interviewed three rural three urban hospital Kenya Uganda costing questionnaire administered caregiver 731 child hospitalised acute illness evaluate direct indirect cost incurred caregiver families Costs incurred compared family child without complicated severe malnutrition CSM Catastrophic outofpocket expenditure exceeding 10 25 monthly income assessed median IQR total cost hospitalisation per child US47 US24US84 higher cost child CSM especially hospitalisation US56 US26US99 v US36 US20US65 p0001 hospitalisation bed charge followed food main cost drivers Caregivers reported losing median 7 411 day productive time childs hospitalisation mean loss income US10 SD US256 median US0 US0US10 92 74 household experienced catastrophic expenditure threshold 10 25 monthly income respectively Caregivers reported borrowing selling property withdrawing child school cope costs Despite intention free healthcare service 5 family acutely ill child commonly faced catastrophic expenditure especially child CSM Interventions aimed supporting financial protection reducing additional healthcare costs lowering health service charge may help prevent catastrophic expenditures",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40017943/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39987229",
        "title": "Improving Malaria diagnosis through interpretable customized CNNs architectures.",
        "abstract": "Malaria spread via female Anopheles mosquito brought Plasmodium parasite persists serious illness especially area high mosquito density Traditional detection techniques like examining blood sample microscope tend laborintensive unreliable necessitate specialized individuals address challenges employed several customized convolutional neural network CNNs including Parallel convolutional neural network PCNN Soft Attention Parallel Convolutional Neural Networks SPCNN Soft Attention Functional Block Parallel Convolutional Neural Networks SFPCNN improve effectiveness malaria diagnosis Among these SPCNN emerged successful model outperforming model evaluation metrics SPCNN achieved precision 9938 ± 021 recall 9937 ± 021 F1 score 9937 ± 021 accuracy 9937 ± 030 area receiver operating characteristic curve AUC 9995 ± 001 demonstrating robustness detecting malaria parasites Furthermore employed various transfer learning TL algorithms including VGG16 ResNet152 MobileNetV3Small EfficientNetB6 EfficientNetB7 DenseNet201 Vision Transformer ViT Dataefficient Image Transformer DeiT ImageIntern Swin Transformer versions v1 v2 proposed SPCNN model surpassed TL method every evaluation measure SPCNN model 2207 million parameter size 26 MB complex PCNN simpler SFPCNN Despite this SPCNN exhibited fastest testing time 000252 s making computationally efficient PCNN SFPCNN assessed model interpretability using feature activation maps Gradientweighted Class Activation Mapping GradCAM SHapley Additive exPlanations SHAP visualization three architectures illustrating SPCNN outperformed others finding experiment show significant improvement malaria parasite diagnosis proposed approach outperforms traditional manual microscopy term accuracy speed study highlight importance utilizing cuttingedge technology develop robust effective diagnostic tool malaria prevention",
        "mesh_terms": [
            "Malaria",
            "Neural Networks, Computer",
            "Humans",
            "Animals",
            "Anopheles",
            "ROC Curve",
            "Algorithms",
            "Female",
            "Plasmodium"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39987229/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39855750",
        "title": "Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis.",
        "abstract": "data treatment child adolescent multidrugresistant MDR rifampicinresistant RR tuberculosis especially recently available drug regimens aimed describe clinical treatment characteristic association treatment outcome susceptible population conducted systematic review individual participant data metaanalysis Databases searched Oct 1 2014 March 30 2020 eligible study must included five child adolescent 019 year age treated microbiologically confirmed clinically diagnosed MDR RR tuberculosis within defined treatment cohort reported regimen composition treatment outcomes Abstracts screened independently two author identify potentially eligible records Full text reviewed two author independently identify study meeting eligiblity criteria study meeting eligiblity criteria anonymised individual patient data requested individiual level data included analysis main outcome assessed treatment outcome defined treatment success cure treatment completed versus unfavourable outcome treatment failure death Multivariable logistic regression model used identify association clinical treatment factor treatment outcomes study registered Prospero CRD42020187230 1417 study identified database searching removing duplicate screening eligibility search identified 23 369 individual participant 42 studies mostly India South Africa Overall 16 825 72·0 successfully treated treatment completed cured 2848 died 12·2 722 3·1 treatment failure 2974 12·7 lost followup primary analyses median age 16 IQR 1318 years 17 764 87·1 participant reported HIV status 2448 13·8 living HIV 17 707 89·6 microbiologically confirmed tuberculosis adjusting significant factor associated treatment outcome use two adjusted odds ratio OR 1·41 95 CI 1·091·82 p0·008 three 2·12 1·612·79 p0·0001 WHOclassified group drug bedaquiline moxifloxacin levofloxacin linezolid compared use group drug positively associated treatment success Younger clinically diagnosed child underrepresented among treated MDR RR tuberculosis focus casefinding efforts Overall treatment outcome analysis better adult lower international target 90 individual successfully treated Treatment group drug associated better treatment outcome child adolescents highlighting need rapid access drug improved regimens Unitaid",
        "mesh_terms": [
            "Humans",
            "Adolescent",
            "Child",
            "Rifampin",
            "Tuberculosis, Multidrug-Resistant",
            "Treatment Outcome",
            "Child, Preschool",
            "Antitubercular Agents",
            "Infant",
            "Male",
            "Female",
            "Antibiotics, Antitubercular"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39855750/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39852670",
        "title": "Integrated Serosurveillance of Infectious Diseases Using Multiplex Bead Assays: A Systematic Review.",
        "abstract": "Integrated serological surveillance serosurveillance involves testing antibody multiple pathogen or species simultaneously achieved using multiplex bead assay MBAs systematic review aim describe pathogen studied using MBAs operational implementation MBAs data generated synthesised November December 2023 four database searched study utilising MBAs integrated serosurveillance infectious diseases Two reviewer independently screened extracted data regarding study setting population methodology seroprevalence results operational implementation elements Overall 4765 study identified 47 eligible inclusion 41 ini  19 investigated multiple malaria species 14 performed concurrent surveillance malaria combination infectious disease ini  14 Additionally 14 study 29 investigated combination multiple infectious disease other malaria seven study examined combination vaccinepreventable diseases Haiti ini  8 studied country followed Ethiopia ini  6 Bangladesh ini  3 Kenya ini  3 Tanzania ini  3 seven study found integrated serosurveillance primary objective synthesis data varied included investigation agespecific seroprevalence ini  25 risk factor analysis ini  15 spatial analysis disease prevalence ini  8 review demonstrated use MBAs integrated surveillance multiple pathogen gaining traction however research capability lower middleincome country needed optimise standardise sample collection survey implementation analysis interpretation results Geographical population seroprevalence data enable targeted public health interventions highlighting potential importance integrated serological surveillance public health tool",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39852670/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39833862",
        "title": "Improving diagnostics and surveillance of malaria among displaced people in Africa.",
        "abstract": "African community forced leave home experience considerably greater susceptibility malaria result densely populated living conditions restricted availability healthcare environmental influences Internally displaced individual frequently live large settlement restricted availability drinking water essential sanitation medical services intensifying spread malaria result occurrence malaria significantly common among refugee internally displaced individual compared displaced lead greater rate illness death especially among young people Insufficient monitoring worsens condition leading delayed identification medical intervention contributing higher incidence severe malaria deaths Furthermore community faced economic consequence contribute continuation poverty worsening socioeconomic inequalities Furthermore psychological impact malaria marked feeling anxiety uncertainty particularly severe vulnerable population displaced child pregnant women aggravating overall burden Hence addressing malaria displaced population Africa requires comprehensive wellcoordinated strategies Advanced diagnostic surveillance technology essential promptly identifying treating malaria providing chance monitor control spread effectively Collaboration among healthcare policy humanitarian sector crucial implementing comprehensive solution incorporate enhanced diagnostics surveillance sociopsychological support Active involvement community usage Community Health Workers regular collection surveillance data crucial increasing awareness directing control efforts tackling specific difficulty encountered displaced groups Moreover implementation environmental management incorporation health services utilization adaptable healthcare intervention essential reducing effect malaria mitigate impact malaria improve health outcome among displaced population Africa crucial focus specific areas",
        "mesh_terms": [
            "Humans",
            "Malaria",
            "Refugees",
            "Africa",
            "Population Surveillance",
            "Female"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39833862/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39795631",
        "title": "The Accuracy of the Passive Leg Raising Test Using the Perfusion Index to Identify Preload Responsiveness-A Single Center Study in a Resource-Limited Setting.",
        "abstract": "bBackgroundb investigated accuracy predicting preload responsiveness mean passive leg raising test PLR using perfusion index PI critically ill patient showing sign hypoperfusion resourcelimited setting bMethodsb carried prospective observational single center study patient admitted sepsis severe malaria sign hypoperfusion Chattogram Bangladesh PLR performed baseline 6 24 48 72 h Preload responsiveness assessed PI compared preload responsiveness assessed cardiac index CI change ≥5 reference test primary endpoint accuracy preload responsiveness prediction PLR using PI baseline secondary endpoint accuracy 6 24 48 72 h Receiver operating characteristic ROC curve constructed bResultsb study included 34 patient admitted sepsis sign hypoperfusion 10 patient admitted severe malaria 168 PLR test performed 143 reliable PI measurement 85 best identified PI change cutoff discriminate responder nonresponders 97 accuracy PLR using PI discriminating preload responsive patient baseline good area ROC 087 95 CI 075099 test showed high sensitivity negative predictive value comparably lower specificity positive predictive value Compared baseline AUROC PLR using PI lower 6 24 48 72 h Restricting analysis sepsis patient change findings bConclusionsb patient sepsis severe malaria sign hypoperfusion change PI PLR test detected preload responsiveness diagnostic accuracy better PI change measured baseline",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39795631/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39738025",
        "title": "Genome sequencing of Plasmodium malariae identifies continental segregation and mutations associated with reduced pyrimethamine susceptibility.",
        "abstract": "Plasmodium malariae parasite widely observed across tropic subtropics slowgrowing species known maintain chronic asymptomatic infections associated reduced antimalarial susceptibility analyse 251 P malariae genome 28 countries leveraging 131601 highquality SNPs demonstrate segregation African Asian isolates Signals recent evolutionary selection identified gene encoding putative surface protein pmmsp1 putative erythrocyte invasion protein pmdpap3 pmrbp2 pmnif4 Amino acid substitution identified orthologs gene associated antimalarial susceptibility including 2 amino acid substitution pmdhfr aligning pyrimethamine resistance mutation P falciparum Additionally characterise pmdhfr mutation F57L demonstrate involvement reduced susceptibility pyrimethamine vitro parasite assay validate CRISPRCas9 mediated ortholog replacement P knowlesi parasite determine function pmdhfr mutation demonstrate circulating pmdhfr genotype less susceptible pyrimethamine",
        "mesh_terms": [
            "Pyrimethamine",
            "Plasmodium malariae",
            "Antimalarials",
            "Drug Resistance",
            "Humans",
            "Mutation",
            "Malaria",
            "Polymorphism, Single Nucleotide",
            "Protozoan Proteins",
            "Genome, Protozoan",
            "Whole Genome Sequencing",
            "Africa",
            "Amino Acid Substitution"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39738025/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39735768",
        "title": "Engaging rural communities in Bangladesh to tackle antimicrobial resistance through the Community Dialogue Approach: a process evaluation protocol for COSTAR project in Cumilla, Bangladesh.",
        "abstract": "Antimicrobial resistance AMR global problem especially threatening lowandmiddle income country like Bangladesh COSTAR Communityled Solutions Antimicrobial Resistance project includes Randomised Control Trial RCT aim evaluate effectiveness Community Dialog Approach CDA improve level correct appropriate knowledge reported practice antibiotics antibiotic use antibiotic resistance ABR One Health perspective among adult community member 5 selected subdistricts Cumilla CDA community engagement approach involving community member active discussion also known Community Dialogs CD run local facilitators dialog promote collective action produce sustainable social change trials process evaluation evaluate fidelity dose adaptation reach mechanism impact process knowledge diffusion using MRC framework evaluation complex interventions process evaluation implemented catchment area 25 selected community clinic CCs intervention group key actor involved process evaluation participant master trainer trainer training community dialog facilitators supervisors community dialog participant nonparticipants local national level government stakeholders Qualitative quantitative data collected Focus Group Discussion FGDs Case Studies Key Informant Interview KIIs CD observations monitoring forms quarterly feedback facilitator supervisors preandposttest questionnaire administered training facilitators qualitative data coded using ia priorii coding framework NVIVO 14 Quantitative data analysed using descriptive statistics Ethical approval obtained Bangladesh Medical Research Council BMRC BMRCNREC20192022427 University Leeds Faculty Medicine Health ethic board MREC 20034 result disseminated one pager summary infographics peerreviewed journal article national international conferences httpswwwisrctncomISRCTN93756764 identifier ISRCTN93756764",
        "mesh_terms": [
            "Female",
            "Anti-Bacterial Agents",
            "Bangladesh",
            "Community Participation",
            "Drug Resistance, Microbial",
            "Health Knowledge, Attitudes, Practice",
            "Rural Population"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39735768/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39700671",
        "title": "Diagnostic techniques for visceral leishmaniasis: An overview of methods used in East Africa.",
        "abstract": "Leishmanias parasitic infection caused protozoan belonging genus Leishmania transmitted sand fly Phlebotomus fly old world Lutzomyia New world disease prevalent tropics subtropics Southern Europe affect 15 million 2 million people annually India Bangladesh Sudan South Sudan Brazil Ethiopia account 90 VL cases Leishmania case Asia declining case East Africa especially Somalia Sudan South Sudan Ethiopia Kenya increasing rise East African case partially attributed ongoing armed conflict especially Somalia Sudan Southern Sudan displaced people increased exposure sand fly bites Migration endemic nonendemic regions misdiagnosis famine malnutrition climate change increase HIV case contributing factors clinical diagnosis Leishmania East Africa combine patients clinical sign either serological parasitological test rK39 strip microscopy major method used Diagnosis condition remains challenging current technique limitations including inability detect parasite tissue need specialized expertise prohibitive cost testing equipment low antibody titers risk misdiagnosis due coinfections disease HIV tuberculosis malaria typhoid Various techniques including serological molecular parasitological methods employed attempt address challenges limited success article therefore review technique used Leishmania diagnosis East Africa discusses available new technique aim overcoming current challenges",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Visceral",
            "Africa, Eastern",
            "Diagnostic Tests, Routine",
            "Leishmania",
            "Animals"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39700671/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39677290",
        "title": "Indian Shot (<i>Canna Indica</i> L). Leaves Provide Valuable Insights into the Management of Inflammation and Other Associated Disorders Offering Health Benefits.",
        "abstract": "Throughout history plant played crucial role advancing medicinal treatment providing diverse range compound development innovative therapies iCanna indicai L tropical herb Cannaceae family also known Indian shot rich history traditional use treating ailment like inflammation malaria dysentery fever dropsy diarrhea comprehensive research invesigates extract preparation iC indicai leaf using multidisciplinary analytical approach extract order shed light therapeutic potentials research international collaboration involving researcher Bangladesh China utilized GCMSMS analysis identify bioactive compound across different iC indicai extracts Biological assay conducted assess antimicrobial activity using disc diffusion method in vitro cytotoxicity brine shrimp lethality assay in vitro analgesic effect via acetic acidinduced writhing test in vivo antidiarrheal activity castor oilinduced diarrhea model in vivo Molecular docking study performed determine binding affinity Epidermal Growth Factor Receptor EGFR Dihydrofolate Reductase DHFR Delta Opioid Receptor DOR Tumor Necrosis Factoralpha TNFα Cyclooxygenase2 COX2 receptors GCMSMS analysis identified 35 43 27 20 compound dichloromethane aqueous petroleum ether ethyl acetate extracts respectively aqueous AQSF dichloromethane DCMSF extract showed notable antimicrobial activity particularly gramnegative bacteria Cytotoxicity test indicated ethyl acetate EASF dichloromethane DCMSF fraction potent Analgesic activity highest DCMSF antidiarrheal effect dosedependent DCMSF showing greatest efficacy Molecular docking revealed strong affinity Ergostane3561225pentol 25acetate 3beta5alpha6beta12beta EGFR Norgestrel COX2 research provides valuable insight bioactivity evaluation iC indicai bridging gap chemical composition diverse biological effects finding contribute growing body knowledge natural productbased drug discovery underscore significance iC indicai potential source novel therapeutic agent treat inflammation disease states",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39677290/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39674185",
        "title": "Regional action needed to halt antimalarial drug resistance in Africa.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39674185/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39658125",
        "title": "The Frequency and Incidence of QT Prolongation With Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country Multidrug-Resistant/Rifampicin-Resistant Tuberculosis Cohort.",
        "abstract": "2022 World Health Organization WHO guideline multidrugresistantrifampicinresistant tuberculosis MDRRRTB recommend 6 month bedaquiline Bdq alloral 9month shorter regimen 6 month longer Bdq delamanid Dlm 1820month longer regimen However lack evidence extended treatment using Bdq Dlm limited use 6 months examine frequency incidence QT prolongation based duration Bdq andor Dlm use longer regimens analyzed prospective cohort MDRRRTB patient 16 country initiated treatment Bdq andor Dlm containing regimen 1 April 2015 30 September 2018 Data systematically collected using shared protocol outcome interest first clinically relevant prolonged QT interval grade 3 above serious adverse event SAE involving prolonged QT grade Among 2553 patients 59 received 6 month Bdq andor Dlm these 579 209 patient experienced prolonged QT event majority 955 grade 1 2 Sixtyfour 25 patient experienced outcome interest 12 05 ≥1 QT prolonging drug permanently suspended incidence rate first prolonged QT event highest first six month treatment lower subsequent 6month periods demonstrate Bdq andor Dlm use beyond 6 month safe longer MDRRRTB regimen clinically relevant QT prolongation event occurring first 6 months Electrocardiogram ECG monitoring early identification QT prolongating event possible programmatic conditions",
        "mesh_terms": [
            "Humans",
            "Diarylquinolines",
            "Antitubercular Agents",
            "Tuberculosis, Multidrug-Resistant",
            "Female",
            "Male",
            "Nitroimidazoles",
            "Long QT Syndrome",
            "Adult",
            "Incidence",
            "Prospective Studies",
            "Middle Aged",
            "Oxazoles",
            "Rifampin",
            "Young Adult",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39658125/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39611671",
        "title": "The silent threat: Unveiling climate change's water and health challenges in Bangladesh.",
        "abstract": "Bangladesh face growing number issues limited source potable water health hazard either directly indirectly linked climate change total 16 publication 2007 2024 manually screened inclusion systematic review article divided three categories climate water climate health climate water health Due climate change 20 million individual Bangladesh suffering water healthrelated illness result showed among Bangladeshi vulnerable groups cholera infant diarrhea pneumonia dengue malaria mental illness hypertension cardiovascular disease cerebrovascular disease increase communicable disease like water vector foodborne infections along malnutrition common finding study include health risks waterrelated risks difficulty determining consequence climate change review study focus Bangladesh developing country correlation climate change danger water healthrelated diseases finding study substantial implication risk assessment water quality climate change public health especially poor nations well policymakers academician fields",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Climate Change",
            "Communicable Diseases",
            "Drinking Water",
            "Public Health",
            "Water Quality",
            "Water Supply"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39611671/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39543999",
        "title": "Addressing Public Health Risks: Strategies to Combat Infectious Diseases After the August 2024 Floods in Bangladesh.",
        "abstract": "August 2024 flood Bangladesh precipitated major public health crisis significantly elevating risk waterborne vectorborne disease exacerbating existing health vulnerabilities disaster impacted 5 million people causing widespread environmental disruption population displacement strained healthcare resources flooding latrines sewage systems agricultural land led contamination drinking water sources increasing risk cholera enterotoxigenic Escherichia coli diarrhoea shigellosis hepatitis Additionally stagnant floodwaters created breeding ground mosquitoes thereby increasing threat malaria dengue fever disruption healthcare service compounded crisis delaying emergency response impeding access care psychological impact affected community profound mental health issue anxiety depression posttraumatic stress disorder emerging significant concerns perspective provides analysis public health threats supported data impact flood discussion underlying risk factors underscore need immediate longterm public health interventions including restoring clean water access enhancing disease surveillance repairing healthcare infrastructure addressing mental health needs response disaster must rapid comprehensive lesson learned inform preparedness effort better manage similar event future",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Floods",
            "Public Health",
            "Risk Factors",
            "Communicable Diseases",
            "Disasters"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39543999/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39485743",
        "title": "Coverage and determinants of Intermittent Preventive Treatment in pregnancy (IPTp) in Cameroon, Guinea, Mali, and Nigeria.",
        "abstract": "Malaria pose serious issue pregnant woman African regions crucial comprehend various factor impact receiving IPTp ANC checkups important wellbeing pregnant mother unborn children Therefore study aim investigate determinant IPTp coverage among woman Cameroon Guinea Mali Nigeria crosssectional study utilized secondary data Malaria Indicator Surveys MIS across Cameroon Guinea Mali Nigeria focusing woman received IPTp pregnancy IPTp categorized dichotomously Yes ANC visit No visits Chisquared test used assess associations binary logistic regression conducted calculate adjusted odds ratios confidence intervals pvalues Results summarized tables found IPTp coverage ANC visit highest Cameroon 986 followed Guinea 977 Mali 971 lowest Nigeria 955 Guinea rural woman less likely receive IPTp urban woman AOR 016 95 CI 007041 p0001 Mali woman received 3 dos less likely receive IPTp ANC AOR 048 p001 Nigeria personal transport increased IPTp uptake AOR 188 p001 Cameroon malaria prevention message improved IPTp coverage AOR 312 p005 study highlight significant disparity IPTp uptake rural Mali Guinea facing lower coverage Nigeria personal transport improved IPTp uptake Targeted intervention needed improve ANC service ensure equitable IPTp access across study regions",
        "mesh_terms": [
            "Humans",
            "Female",
            "Pregnancy",
            "Adult",
            "Cameroon",
            "Mali",
            "Nigeria",
            "Cross-Sectional Studies",
            "Malaria",
            "Antimalarials",
            "Guinea",
            "Young Adult",
            "Prenatal Care",
            "Adolescent",
            "Pregnancy Complications, Parasitic",
            "Rural Population"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39485743/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39488222",
        "title": "The 2024 report of the Lancet Countdown on health and climate change: facing record-breaking threats from delayed action.",
        "abstract": "Despite initial hope inspired 2015 Paris Agreement world dangerously close breaching target limiting global multiyear mean heating 1·5°C Annual mean surface temperature reached record high 1·45°C preindustrial baseline 2023 new temperature high recorded throughout 2024 resulting climatic extreme increasingly claiming life livelihood worldwide iLanceti Countdown tracking progress health climate change established year Paris Agreement entered force monitor health impact opportunity world’s response landmark agreement Supported strategic core funding Wellcome collaboration brings together 300 multidisciplinary researcher health professional around world take stock annually evolving link health climate change global regional national levels 2024 report iLanceti Countdown building expertise 122 leading researcher UN agency academic institution worldwide reveals concerning finding yet collaboration’s 8 year monitoring Data year’s report show people around world facing recordbreaking threat wellbeing health survival rapidly changing climate 15 indicator monitoring climate changerelated health hazards exposures impacts ten reached concerning new record recent year data Heatrelated mortality people older 65 year increased recordbreaking 167 compared 1990s 102 percentage point higher 65 would expected without temperature rise indicator 115 Heat exposure also increasingly affecting physical activity sleep quality turn affecting physical mental health 2023 heat exposure put people engaging outdoor physical activity risk heat stress moderate higher record high 27·7 hour average 1990s indicator 112 led record 6 hour sleep lost 2023 average 1986–2005 indicator 114 People worldwide also increasingly risk lifethreatening extreme weather events 1961–90 2014–23 61 global land area saw increase number day extreme precipitation indicator 123 turn increase risk flooding infectious disease spread water contamination parallel 48 global land area affected least 1 month extreme drought 2023 second largest affected area since 1951 indicator 122 increase drought heatwave event since 1981–2010 was turn associated 151 million people experiencing moderate severe food insecurity across 124 country assessed 2022 highest recorded value indicator 142 hotter drier weather condition increasingly favouring occurrence sand dust storms weatherenvironmental phenomenon contributed 31 increase number people exposed dangerously high particulate matter concentration 2003–07 2018–22 indicator 124 Meanwhile changing precipitation pattern rising temperature favouring transmission deadly infectious disease dengue malaria West Nile virusrelated illness vibriosis putting people risk transmission previously unaffected location indicators 131–134 Compounding impacts climate change affecting social economic condition health wellbeing depend average annual economic loss weatherrelated extreme event increased 23 2010–14 2019–23 US227 billion a value exceeding gross domestic product GDP 60 world’s economies indicator 411 Although 60·5 loss high Human Development Index HDI country covered insurance vast majority country lower HDI level uninsured local community bearing brunt physical economic loss indicator 411 Extreme weather climate changerelated health impact also affecting labour productivity heat exposure leading record high loss 512 billion potential labour hour 2023 worth 835 billion potential income loss indicators 113 413 Low medium HDI country affected losses amounted 7·6 4·4 GDP respectively indicator 413 underserved community affected economic impact reduce capacity cope recover growing impact climate change thereby amplifying global inequities Concerningly multiple hazard revealed individual indicator likely simultaneous compounding cascading impact complex interconnected human system sustain good health disproportionately threatening people’s health survival every fraction degree increase global mean temperature Despite year monitoring exposing imminent health threat climate inaction health risk people face exacerbated year delay adaptation left people illprotected growing threat climate change 68 country reported hightoveryhigh implementation legally mandated health emergency management capacity 2023 11 low HDI country indicator 225 Moreover 35 country reported health early warning system heatrelated illness whereas 10 mental psychosocial condition indicator 221 Scarcity financial resource identified key barrier adaptation including 50 city reported planning undertake climate change health risk assessment indicator 213 Indeed adaptation project potential health benefit represented 27 Green Climate Fund’s adaptation funding 2023 despite 137 increase since 2021 indicator 224 universal health coverage still unattained countries financial support needed strengthen health system ensure protect people growing climate changerelated health hazards unequal distribution financial resource technical capacity leaving vulnerable population unprotected growing health risks well exposing inadequacy adaptation effort date year’s report reveals world veering away goal limiting temperature rise 1·5°C concerning new record broken across indicator monitoring greenhouse gas emission condition enable them Far declining global energyrelated COsub2sub emission reached alltime high 2023 indicator 311 Oil gas company reinforcing global dependence fossil fuel and—partly fuelled high energy price windfall profit global energy crisis—most expanding fossil fuel production plans March 2024 114 largest oil gas company track exceed emission consistent 1·5°C heating 189 2040 173 1 year indicator 422 result strategy pushing world track meeting goal Paris Agreement threatening people’s health survival Although renewable energy could provide power remote locations adoption lagging particularly vulnerable countries consequence delay reflect human impact unjust transition Globally 745 million people still lack access electricity facing harm energy poverty health wellbeing burning polluting biomass eg wood dung still account 92 energy used home people low HDI country indicator 312 2·3 electricity country come clean renewables compared 11·6 high HDI country indicators 311 persistent burning fossil fuel biomass led least 3·33 million death outdoor fine particulate matter PMsub2·5sub air pollution globally 2021 alone indicator 321 domestic use dirty solid fuel caused 2·3 million death indoor air pollution 2020 across 65 country analysed indicator 322 Compounding growth energyrelated greenhouse gas emissions almost 182 million hectare forest lost 2016 2022 indicator 34 reducing world’s natural capacity capture atmospheric COsub2sub parallel consumption red meat dairy products contributed 11·2 million death attributable unhealthy diet 2021 indicator 332 led 2·9 increase agricultural greenhouse gas emission since 2016 indicator 331 Health system themselves although essential protect people’s health also increasingly contributing problem Greenhouse gas emission health care increased 36 since 2016 making health system increasingly unprepared operate net zero emission future pushing health care guiding principle harm indicator 35 growing accumulation greenhouse gas atmosphere pushing world future increasingly dangerous health hazard reducing chance survival vulnerable people around globe availability financial resource key barrier tackling climate change rapid growth predictable equitable investment urgently needed avoid dangerous impact climate change growing body literature show economic benefit transition net zero greenhouse gas emission far exceed cost inaction Healthier resilient population support prosperous sustainable economy indicators 412–414 However although funding enable potentially lifesaving climate change adaptation mitigation activity remains scarce substantial financial resource allocated activity harm health perpetuate fossil fuelbased economy resulting reliance fossil fuel energy meant many country faced sharp increase energy price following Russia’s invasion Ukraine resulting disruption fossil fuel supplies keep energy affordable local populations many government resorted increasing explicit fossil fuel subsidies Consequently 84 country studied still operated net negative carbon price explicit net fossil fuel subsidies 2022 record high net total 1·4 trillion indicator 433 sum involved often comparable countries’ total health budgets addition although clean energy investment grew 10 globally 2023—exceeding fossil fuel investment 73—considerable regional disparity exist Clean energy investment 38 lower fossil fuel spending emerging market developing economy outside China Clean energy spending country accounted 17·4 global total Moreover investment energy efficiency end use essential transition decreased 1·3 2023 indicator 431 resulting expansion fossil fuel asset increasingly jeopardising economy people’s livelihood depend current trajectory world already face potential global income loss ranging 11 29 2050 number fossil fuel industry employee reached 11·8 million 2022 increasing size workforce whose employment cannot sustained world avoids catastrophic human impact climate change indicator 421 Meanwhile ongoing investment coal power pushed value coalfired power generation asset risk becoming stranded within 10 year between 2025 2034 1·5°C trajectory cumulative total 164·5 billion—a value increase coal investment persist indicator 423 prioritisation fossil fuelbased system mean country remain illprepared vital transition zero greenhouse gas emission economies result unjust transition risk unequally distributed preparedness score transition net zero greenhouse gas economy global average country low HDI 96 medium HDI 84 high HDI compared 7 high HDI country indicator 424 Following decade delay climate change action avoiding severe health impact climate change requires aligned structural sustained change across human systems including energy transportation agriculture food health care Importantly global transformation financial system required shifting resource away fossil fuelbased economy towards zero emission future Putting people’s health centre climate change policy making key ensuring transition protects wellbeing reduces health inequities maximises health gains indicator reveal incipient progress important opportunity delivering healthcentred transformation December 2023 50 country reported formally assessed health vulnerability adaptation needs 11 previous year number country reported Health National Adaptation Plan increased four 2022 43 2023 indicators 211 212 Additionally 70 279 public health education institution worldwide reported providing education climate health 2023 essential build capacity health professional help shape transition indicator 226 Regarding energy sector global share electricity clean modern renewables reached record high 10·5 2021 indicator 311 clean energy investment exceeded fossil fuel investment 73 2023 indicator 431 renewable energyrelated employment grown 35·6 since 2016 providing healthier sustainable employment opportunity fossil fuel industry indicator 421 Importantly mostly result coal phasedown high high HDI countries death attributable outdoor PMsub2·5sub fossil fuel combustion decreased 6·9 2016 2021 indicator 321 showing lifesaving potential coal phaseout Important progress made within international negotiations opened new opportunity protect health face climate change year leadership climate change health Fourteenth General Programme Work adopted May 2024 made responding climate change first strategic priority Within climate negotiation themselves 28th Conference Parties COP28 United Nations Framework Convention Climate Change UNFCCC featured first health thematic day 2023 151 country endorsed COP28 United Arab Emirates Declaration Climate Health Global Goal Adaptation set specific health target outcome first Global Stocktake Paris Agreement also recognised right health healthy environment urging party take health adaptation efforts opened new opportunity human survival health wellbeing prioritised updated Nationally Determined Contributions NDCs due 2025 pending decision Loss Damage fund governed definition New Collective Quantified Goal Climate Finance COP29 provide opportunity secure financial support crucial healthy net zero transition Although still insufficient protect people’s health climate change emerging sign progress help open new opportunity deliver healthy prosperous future However much remains done climate change breaking dangerous new record emission persistently rising preventing catastrophic consequence human development health survival requires support actor society However data suggest engagement health climate change could declining across key sectors number government mentioning health climate change annual UN General Debate statement fell 50 2022 35 2023 47 58 NDCs updated February 2024 referred health indicator 541 Media engagement also dropped proportion newspaper climate change article mentioning health falling 10 2022 2023 indicator 51 powerful trusted leadership health community could hold key reversing concerning trend making people’s wellbeing health survival central priority political financial agendas engagement health professional level climate change decision making pivotal informing redirection effort financial resource away activity jeopardise people’s health towards supporting healthy populations prosperous economies safer future concerning record continue broken people face unprecedented risk climate change wellbeing health survival individual every country hang balance",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39488222/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39455950",
        "title": "Assessing the role of the for-profit private healthcare sector in malaria elimination efforts in Bangladesh: a cross-sectional study of challenges and opportunities.",
        "abstract": "Among 13 endemic districts Chittagong Hill Tracts bear 90 Bangladeshs malaria burden Despite private sectors prominence rural healthcare role malaria management remains underutilized study aimed strategize leveraging forprofit private sector diagnostic treatment centers bolster national malaria surveillance control advancing Bangladesh toward malaria elimination 2030 mixedmethod study commenced questionnairebased crosssectional survey followed selected focused group discussion FGDs among participants Three FGDs held forprofit service provider insight qualitative viewpoint utilized situation analysis Based endemicity strategic priorities comprehensive mapping private forprofit facility region comprising 15 subdistricts across 8 chosen district 7 malaria endemic district rest nonendemic districts created nonendemic zone subdistricts selected based proximity area high malaria transmission Among 104 representative participants majority male n  92 885 diploma respective field n  53 51 involved either laboratory work n  49 471 ownersmanagers health center n  41 394 selected health facility close corresponding Upazila Health Complexes mean distance 28 km distantly located designated district hospital mean distance 489 km main source RDT kit 623 antimalarial drug 632 local wholesale markets large share corresponding facility neither provided malaria treatment service 817 worked NMEP 933 study highlight challenge recommendation engaging private forprofit health facility Bangladeshs malaria elimination efforts identified challenge include lowquality RDTs staff shortages inadequate capacity building Recommendations emphasize effective training stakeholder interaction enhanced oversight successful malaria control efforts",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "Bangladesh",
            "Malaria",
            "Private Sector",
            "Male",
            "Female",
            "Surveys and Questionnaires",
            "Disease Eradication",
            "Adult",
            "Focus Groups",
            "Middle Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39455950/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39448997",
        "title": "The predictive capacity of biomarkers for clinical pulmonary oedema in patients with severe falciparum malaria is low: a prospective observational study.",
        "abstract": "Pulmonary oedema feared difficult predict complication severe malaria emerge start antimalarial treatment Proinflammatory mediator thought play central role pathogenesis exploratory study conducted evaluate predictive capacity biomarkers development clinical pulmonary oedema patient severe falciparum malaria two hospital Bangladesh Plasma concentration interleukin6 IL6 IL8 tumour necrosis factor TNF soluble Receptor Advanced Glycation Endproducts sRAGE surfactant proteinD SPD club cell secretory protein CC16 Krebs von den Lungen6 KL6 admission compared healthy controls Correlations biomarker plasma lactate Plasmodium falciparum histidinerich protein 2 PfHRP2 level evaluated Receiver Operating Characteristic ROC curve constructed assess predictive capacity clinical pulmonary oedema biomarkers interest 106 screened patient falciparum malaria 56 classified severe malaria mortality rate 29 Nine 16 patient developed clinical pulmonary oedema admission Plasma level biomarkers interest higher patient compared healthy controls IL6 IL8 TNF sRAGE CC16 level correlated well plasma PfHRP2 level rsubssub  039 P  0004 rsubssub  043 P  0001 rsubssub  054 P  0001 rsubssub  044 P  0001 rsubssub  043 P  0001 respectively Furthermore IL6 IL8 level correlated well plasma lactate level rsubssub  037 P  0005 rsubssub  047 P  0001 respectively None biomarkers interest predictive capacity development clinical pulmonary oedema IL6 IL8 TNF sRAGE SPD CC16 KL6 cannot used predicting clinical pulmonary oedema severe malaria patients",
        "mesh_terms": [
            "Humans",
            "Pulmonary Edema",
            "Biomarkers",
            "Prospective Studies",
            "Male",
            "Malaria, Falciparum",
            "Female",
            "Adult",
            "Bangladesh",
            "Young Adult",
            "Middle Aged",
            "Adolescent",
            "Cytokines",
            "Antigens, Protozoan",
            "ROC Curve",
            "Protozoan Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39448997/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39419055",
        "title": "Global health 2050: the path to halving premature death by mid-century.",
        "abstract": "Global health 2050 GH2050 new report Lancet Commission Investing Health find dramatic improvement human welfare achievable midcentury focused health investments 2050 country choose halve probability premature death PPD—the probability dying age 70—from prepandemic level 2019 call goal “50 50” 50 reduction PPD 2050 intervention achieving “50 50” also reduce morbidity disability ages Historical experience continued scientific advance indicate feasible aspiration Eight 30 populous country reduced PPD last decade rate would halve PPD 2050 including country diverse Bangladesh Iran Tanzania Turkey focused gain achieved relatively early pathway full universal health coverage UHC path achieving “50 50” run control remarkably narrow set 15 conditions currently high mortality countries eight infectious disease maternal condition highest priority Seven cluster noncommunicable disease injury important everywhere addressing prove central achieving “50 50” country lower initial level mortality Focused attention health system strengthening HSS primary care first level hospital generate capacity better tackle 15 priority condition critical step way improving capacity address condition UHC package Packaging intervention 19 module eg childhood immunization module module cardiovascular disease prevention lowcost widely available treatment address 15 priority conditions Adopting focused approach also invests key area HSS address major morbidities psychiatric illness already covered mortalityreducing interventions Value money assessed twostep process technical cost effectiveness assess best achieve modulespecific goal eg reduction child mortality reduction cardiovascular mortality political evaluation tradeoff investing expanding module coverage many country seeking reform standard budgetary mechanism failed successfully reorient system toward priority intervention improve health mechanism blanket budget transfer ministry finance ministry health fit support reorientation Commission concluded problem could addressed directing substantial increasing fraction budget transfer making available affordable specific drugs vaccines diagnostics commodity currently available control 15 priority conditions Drug availability affordability typically require four complementary components i redirecting general budget transfer line item transfer subsidies specific priority drugs ii centralized procurement government or perhaps internationally iii procurement sufficient volume ensure availability needed iv use strengthening existing supply chains public private many intersectoral policy government adopt help achieve “50 50” tobacco control far important given number death caused tobacco established improving capacity government implement tobacco policy high level tobacco taxation essential valuable short medium term public finance accompanied package effective tobacco control policies Background research conducted Commission point exceptionally high ongoing level mortality risk pandemics Country performance COVID19 varied greatly although eventual vaccine availability attenuated far eliminated variability end COVID19’s emergency phase National implementation public health fundamentals—early action isolation infected individuals quarantining exposed social financial support people isolating quarantining—accounted much success bestperforming nations Japan next pandemic fundamental help avert mortality waiting vaccine development deployment conclusion primarily aimed national governments final conclusion aimed development assistance community conclude assistance focus two broad purposes first provide direct financial technical support country least resources—to help develop health system better control diseases second finance global public goods including strengthening data systems reducing development spread antimicrobial resistance preventing responding pandemics fostering global health leadership advocacy identifying spreading best practices developing deploying new health technologies purposes focusing effort 15 priority condition would best contribute “50 50” decade ago malaria vaccine available tuberculosis vaccine low efficacy Today two partially successful malaria vaccine approved three promising tuberculosis vaccine candidate late stage trials success exemplify enormous value funding development new medicines vaccines diagnostics operational research 15 priority conditions prize “50 50” interim milestone “30 2035” a 30 reduction PPD 2035 remains prize within reach efficient route focus resource narrow set condition scale financing develop deploy new health technologies economic analysis shown value achievable mortality decline remains high indeed often substantial fraction value gain gross domestic product Today case better ever value investing health reducing mortality morbidity alleviating poverty growing economies improving human welfare",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39419055/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39406200",
        "title": "Cerebral Venous Sinus Thrombosis: Current Updates in the Asian Context.",
        "abstract": "Cerebral venous sinus thrombosis CVT lifethreatening cause stroke Asian countries South Asia comprising India Pakistan Bangladesh contributed 40 stroke women Major CVT registry Western nations differs Asian country respect epidemiology gender biases risk factors review focus various aspect relevance evaluation management patient CVT Asian context incidence CVT higher Asia Western nations Young age female gender especially pregnancy puerperal period dehydration appear critical risk factors Tropical infection like malaria scrub typhus flaviviral encephalitis predispose CVT higher prevalence inherited thrombophilia Asian cohorts contributing prothrombotic states Anticoagulation supportive management offer excellent outcomes Newer anticoagulant safe efficacious medically refractory cases endovascular treatment offer modest benefits Decompressive hemicraniectomy done early offer mortality benefit patient large hemorrhagic venous infarctions CVT important cause stroke high burden South Asian countries Establishment robust registry need hour study natural history course outcome develop management algorithm tailored available resources",
        "mesh_terms": [
            "Humans",
            "Sinus Thrombosis, Intracranial",
            "Risk Factors",
            "Incidence",
            "Asia",
            "Anticoagulants",
            "Female",
            "Male",
            "Treatment Outcome",
            "Prevalence",
            "Stroke",
            "Risk Assessment",
            "Adult",
            "Asian People",
            "Middle Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39406200/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39399862",
        "title": "Bangladesh should engage the private sector for malaria elimination by 2030.",
        "abstract": "Bangladesh reduced malaria incidence 93 2008 2020 action governmental nongovernmental organizations Bangladesh context unique South Asia successful public sector malaria control program historically engaged corporate partner as undertaken Sri Lanka proposed India However ∼18 million people continue live risk infection Bangladesh forprofit private healthcare providers catalytic malaria elimination many countries expected benefit national program distilled from large complex literature nine distinct strategy important developing setting weighed context Bangladeshs flourishing private health care sector driven patient demand selfinterest aspiration public good well heterogeneity provider malariaprevalence propose new model dependent five strategy immediate deployment consideration high endemic areas empower Bangladeshs phased agenda eliminating indigenous malaria transmission 2030",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39399862/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39351718",
        "title": "Clinicopathological Evaluation of the Patients with Febrile Illness and Altered Consciousness Admitted in a Tertiary Level Hospital.",
        "abstract": "important note altered mental status disease itself rather symptom wide range potential diagnoses structured approach assessing patient symptom frequently lead helpful information rule worstcase scenarios case fever followed change consciousness quick assessment patients level consciousness potential cause decisive focused history physical assessment help differentiate structural medical causes Asymmetrical neurological findings dilated fixed pupil dysconjugated extraocular movement asymmetrical motor findings suggest brainstem dysfunction due structural lesion symmetrical neurological finding usually indicate medical disorder recent study aimed identify feature different etiologies demographic patterns common cause acute prolonged febrile illness patients crosssectional type observational study conducted Department Medicine Mymensingh Medical College Hospital Bangladesh April 2014 October 2015 study period patient admitted satisfying inclusion exclusion criterion study purposively selected nonprobability hospitalized patients Total 100 case febrile illness altered consciousness meeting exclusion inclusion criterion examined investigated find actual etiology 100 patients observed 26260 patient suffering pneumonia 22220 urinary tract infection 18180 meningitis 14140 typhoid fever 880 meningoencephalitis 660 cerebral malaria 440 tuberculosis 220 tuberculoma result revealed large number patient febrile illness altered consciousness suffering pneumonia urinary tract infection",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Fever",
            "Consciousness Disorders",
            "Adult",
            "Middle Aged",
            "Cross-Sectional Studies",
            "Tertiary Care Centers",
            "Adolescent",
            "Young Adult",
            "Aged",
            "Child",
            "Bangladesh"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39351718/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39345873",
        "title": "Employing Hexahydroquinolines as <i>Pf</i>CDPK4 Inhibitors to Combat Malaria Transmission: An Advanced Computational Approach.",
        "abstract": "Existing antimalarial drug primarily target bloodstage parasites need transmissionblocking drug combat malaria effectively iPlasmodium falciparumi Calciumdependent Protein Kinase 4 CDPK4 promising target drugs study employed advanced silico analysis hexahydroquinolines HHQ derivative identify iPfiCDPK4 inhibitor capable disrupting malaria transmission Structurebased virtual screening SBVS employed discover HHQ derivative highest binding affinity 3D structure iPfiCDPK4 PDB 1D 4QOX Interaction analysis proteinligand complex utilized Discovery Studio Client druglikeness ADMET property assessed using SwissADME pkCSM web servers respectively Quantum mechanical calculation top hit conducted using density functional theory DFT GROMACS employed perform molecular dynamic MD simulations Binding free energy predicted using MMPBSApy tool AMBER package SBVS identified ten best hit possessing docking score within range 112 kcalmol 106 kcalmol surpassing known inhibitor BKI1294 99 kcalmol Among these 44Furan2carbonylpiperazin1yl1naphthalen2ylmethyl2oxo4a56788ahexahydroquinoline3carbonitrile PubChem ID 145784778 exhibited highest binding affinity 112 kcalmol iPfiCDPK4 Comparative analysis compound BKI1294 using advanced computational approach demonstrated competitive potential finding suggest potential 44Furan2carbonylpiperazin1yl1naphthalen2ylmethyl2oxo4a56788ahexahydroquinoline3carbonitrile promising iPfiCDPK4 inhibitor disrupting malaria transmission However experimental study warranted validate efficacy safety profile",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39345873/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39226053",
        "title": "Neurological Symptoms and Cause of Death Among Young Children in Low- and Middle-Income Countries.",
        "abstract": "emergence acute neurological symptom child necessitates immediate intervention Although low middleincome country LMICs bear highest burden neurological diseases scarcity diagnostic therapeutic resources Therefore current understanding etiology neurological emergency LMICs relies mainly clinical diagnosis verbal autopsies characterize association premortem neurological symptom management postmortemconfirmed cause death among child aged younger 5 year LMICs identify current gap improve strategy enhance child survival crosssectional study conducted December 3 2016 July 22 2022 7 participating site Child Health Mortality Prevention Surveillance CHAMPS network Bangladesh Ethiopia Kenya Mali Mozambique Sierra Leone South Africa Minimally invasive tissue sampling performed CHAMPS site specimen deceased child aged younger 5 years study included deceased child underwent premortem neurological evaluation postmortemconfirmed cause death Data analysis performed July 22 2022 January 15 2023 Descriptive analysis performed using neurological evaluation premortem clinical record postmortem determination cause death based histopathology microbiological testing clinical records verbal autopsies 2127 death child codified study period 1330 625 neurological evaluation recorded included analysis 1330 child median age 11 IQR 2324 days 745 560 male 727 547 presented neurological symptom illness death common postmortemconfirmed neurological diagnosis related death hypoxic event 308 232 meningoencephalitis 135 102 cerebral malaria 68 51 12 neonate overlapping hypoxic event meningoencephalitis patient overlapping meningoencephalitis cerebral malaria Neurological symptom similar among diagnoses combination symptom accurate differentiating without complementary tools However 25 child 185 meningitis lumbar puncture performed death Nearly 90 death 442 511 865 neurological diagnosis chain event leading death considered preventable crosssectional study child aged younger 5 years neurological symptom frequent death However clinical phenotype insufficient differentiate common underlying neurological diagnoses low rate lumbar puncture performed especially worrying suggesting challenge quality care child presenting neurological symptoms Improved diagnostic management neurological emergency necessary ultimately reduce mortality vulnerable population",
        "mesh_terms": [
            "Humans",
            "Infant",
            "Child, Preschool",
            "Male",
            "Cross-Sectional Studies",
            "Female",
            "Developing Countries",
            "Cause of Death",
            "Nervous System Diseases",
            "Kenya",
            "Infant, Newborn",
            "South Africa",
            "Bangladesh",
            "Ethiopia",
            "Sierra Leone",
            "Mali",
            "Mozambique",
            "Autopsy"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39226053/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39214233",
        "title": "Impact of climate change on vector-borne diseases: Exploring hotspots, recent trends and future outlooks in Bangladesh.",
        "abstract": "Climate change significant risk multiplier profoundly influence transmission dynamics geographical distribution resurgence vectorborne disease VBDs Bangladesh noticeable rise VBDs attributed climate change Despite severity issue interconnection climate change VBDs Bangladesh yet thoroughly explored address research gap review meticulously examined existing literature relationship climate change VBDs Bangladesh Using Preferred Reporting Items Systematic Reviews MetaAnalyses PRISMA approach identified 3849 record SCOPUS Web Science Google Scholar databases Ultimately 22 research article meeting specific criterion included identified literature subject matter study noncontemporaneous 68 study investing datasets 2014 despite study climate change dengue nexus increased recently pinpointed Dhaka Chittagong Hill Tracts dengue malaria research hotspots respectively highlighted 2023 dengue outbreak illustrates possible shift dengueendemic area Bangladesh Moreover dengue case surged 317 2023 compared 2019 records corresponding 607 increase mortality compared 2022 weak connection observed dengue incident climate drivers including El Niño Southern Oscillation ENSO Indian Ocean Dipole IOD However compelling evidence supported association malaria cases Sea Surface Temperature SST Bay Bengal along NINO3 phenomenon observed minimal microclimatic nonclimatic data inclusion selected studies review hold implication policymakers urging prioritization mitigation measure yearround surveillance early warning systems Ultimately call resource allocation empower researcher advancing understanding VBD dynamic amidst changing climates",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Bangladesh",
            "Climate Change",
            "Dengue",
            "Disease Outbreaks",
            "Malaria",
            "Vector Borne Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39214233/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39154665",
        "title": "Effects of prenatal small-quantity lipid-based nutrient supplements on pregnancy, birth, and infant outcomes: a systematic review and meta-analysis of individual participant data from randomized controlled trials in low- and middle-income countries.",
        "abstract": "Undernutrition pregnancy increase risk giving birth small vulnerable newborn Smallquantity lipidbased nutrient supplement SQLNSs contain macro micronutrient help prevent multiple nutritional deficiencies examined effect SQLNSs provided pregnancy compared 1 iron folic acid standard care IFASOC 2 multiple micronutrient supplement MMSs identified characteristic modified estimate effect SQLNSs birth outcomes conducted 2stage metaanalysis individual participant data 4 randomized controlled trial SQLNSs provided pregnancy n  5273 generated studyspecific subgroup estimate SQLNS compared IFASOC MMS pooled estimates sensitivity analyses examined whether result differed depending method gestational age dating birth anthropometry study design SQLNSs compared IFASOC increased birth weight mean difference 49 g 95 confidence interval CI 26 71 g birth anthropometric zscores 010013 standard deviation reduced risk low birth weight 11 newborn stunting 17 newborn wasting 11 small head size 15 2 trial compared SQLNSs MMSs P value birth outcome 010 except head circumference eg zscore gestational age 011 95 CI 001 023 Effect estimate SQLNSs compared IFASOC greater among female infant and certain outcomes among mother body mass index 20 kgmsup2sup inflammation malaria household food insecurity Effect estimate SQLNSs compared MMSs greater certain outcome among female infants firstborn infants mother 25 y SQLNSs positive impact multiple outcome compared IFASOC research directly comparing SQLNSs MMSs needed Targeting SQLNSs vulnerable subgroup may worth considering study registered PROSPERO CRD42021283391",
        "mesh_terms": [
            "Female",
            "Humans",
            "Infant, Newborn",
            "Pregnancy",
            "Birth Weight",
            "Developing Countries",
            "Dietary Supplements",
            "Infant, Low Birth Weight",
            "Lipids",
            "Micronutrients",
            "Pregnancy Outcome",
            "Prenatal Care",
            "Prenatal Nutritional Physiological Phenomena",
            "Randomized Controlled Trials as Topic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39154665/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38995021",
        "title": "Discovery of new antigens for serodiagnosis of visceral leishmaniasis in humans and dogs adds valuable tools to our arsenal.",
        "abstract": "Surveillance sustained control visceral leishmaniasis VL require reliable serodiagnostic tools rK39 gold standard antigen VL diagnosis limited documented poor sensitivity certain endemic regions East Africa longevity antibodies making difficult distinguish active cured infections recent publication imBioi Roberts et al A J Roberts HB Ong S Clare C Brandt et al mBio 15e0085924 2024 httpsdoiorg101128mbio0085924 identified new immunogenic iLeishmaniai candidate dog humans dogs combined antigen LdBPK2907901  LdBPK3627001 D4 D46 distinguished symptomatic asymptomatic infections humans LdBPK3236001 D36 antigen produced shortlived antibody performed well patient cohort Bangladesh Ethiopia Kenya study add promising new candidate serodiagnostic toolbox highlight need antigen discovery study may focused regional performance",
        "mesh_terms": [
            "Leishmaniasis, Visceral",
            "Dogs",
            "Animals",
            "Antigens, Protozoan",
            "Serologic Tests",
            "Humans",
            "Dog Diseases",
            "Antibodies, Protozoan",
            "Sensitivity and Specificity",
            "Ethiopia"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38995021/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38992660",
        "title": "The spectrum of health conditions in community-based cross-sectional surveys in Southeast Asia 2010-21: a scoping review.",
        "abstract": "Southeast Asia undergoing epidemiological transition noncommunicable illness becoming increasingly important yet infectious disease tuberculosis HIV hepatitis B malaria remain widely prevalent populations emerging zoonotic disease threaten also limited populationlevel estimate many important heath conditions restricts evidencebased decisionmaking disease control prevention priorities Crosssectional survey efficient epidemiological tool measure prevalence wide range diseases systematic assessment coverage different health condition produced region conducted systematic search Medline Embase Global Health CINAHL Scopus Web Science Core Collection Global Index Medicus additionally Google Scholar inclusion criterion crosssectional survey conducted communitybased recruitment Bangladesh Cambodia Laos Myanmar Thailand published January 1 2010 January 27 2021 reporting prevalence health condition 542 publication 337 survey included Noncommunicable condition n  205 reported survey infectious condition n  124 Disability n  49 selfreport history disease symptom n  35 selfperceived health status n  34 reflect holistic picture health studied many fewer surveys addition 45 survey studied symptomatic condition overlap noncommunicable infectious conditions surveyed condition undernutrition obesity hypertension diabetes intestinal parasites malaria anemia diarrhea fever acute respiratory infections condition overlap important cause death disability Global Burden Disease study However highburden condition eg hearing loss headache disorder low back pain chronic liver kidney diseases cancers rarely studied relatively recent survey estimate representative prevalence trend health condition beyond known high burden Expanding spectrum health condition crosssectional survey could improve understanding evolving disease pattern region",
        "mesh_terms": [
            "Humans",
            "Asia, Southeastern",
            "Communicable Diseases",
            "Cross-Sectional Studies",
            "Health Status",
            "Health Surveys",
            "Noncommunicable Diseases",
            "Prevalence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38992660/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38972560",
        "title": "Seasonal variability and stochastic branching process in malaria outbreak probability.",
        "abstract": "Malaria worlds fatal challenging parasitic disease caused Plasmodium parasite transmitted human bite infected female mosquitoes Bangladesh vulnerable region spread malaria geographic position paper considered dynamic vectorhost model observed stochastic behavior study elaborates seasonal variability calculates probability disease outbreaks present model malaria disease transmission develop corresponding continuoustime Markov chain CTMC representation proposed vectorhost model illustrate malaria transmission model along sensitivity analysis deterministic model CTMC curve depicted show randomness real scenarios Sequentially expand study timevarying stochastic vectorhost model incorporates seasonal variability Phase plane analysis conducted explore characteristic disease examine interaction among various compartments evaluate impact key parameters branching process approximation developed corresponding vectorhost model calculate probability outbreak Numerous numerical result accomplished observe analytical investigation Seasonality contact pattern affect dynamic disease outbreaks numerical illustration provides probability disease outbreak depends infected host vector Additionally periodic transmission rate great influence probability outbreak basic reproduction number Rsub0sub derived main justification studying dynamical behavior epidemic models Seasonal variability significantly impact malaria transmission probability disease outbreak influenced time initial number infected individuals Moreover branching process approximation applicable population size large enough basic reproduction number less 1 future analysis help decisionmakers understand impact various parameter stochastic behavior vectorhost model prevent type disease outbreaks",
        "mesh_terms": [
            "Seasons",
            "Humans",
            "Disease Outbreaks",
            "Malaria",
            "Animals",
            "Mosquito Vectors",
            "Bangladesh",
            "Stochastic Processes",
            "Probability",
            "Female",
            "Markov Chains"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38972560/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38971837",
        "title": "A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults.",
        "abstract": "preparation mass vaccination R21MatrixM™ combined mass administration dihydroartemisinin piperaquine single low dose primaquine assessed tolerability safety potential interaction combination affecting immunogenicity pharmacokinetics 120 healthy Thai volunteer randomised receive either antimalarial combined vaccination n  50 vaccination alone n  50 antimalarial n  20 Three round vaccine antimalarial administered one month apart vaccine well tolerated alone combination antimalarials None participant failed completion 3dose vaccine course significant difference vaccine immunogenicity pharmacokinetics piperaquine given individually combination study support proceeding large trial mass vaccination R21MatrixM™ combined mass antimalarial administration Bangladesh",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38971837/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38739632",
        "title": "Influence of hydrometeorological risk factors on child diarrhea and enteropathogens in rural Bangladesh.",
        "abstract": "number study detected relationship weather diarrhea investigated association specific enteric pathogens Understanding pathogenspecific relationship weather crucial inform public health lowresource setting especially vulnerable climate change objective identify weather environmental risk factor associated diarrhea enteropathogen prevalence young child rural Bangladesh population high diarrheal disease burden vulnerability weather shift climate change matched temperature precipitation surface water humidity data observational longitudinal data clusterrandomized trial measured diarrhea enteropathogen prevalence child 6 months55 year 20122016 fit generalized additive mixed model cubic regression spline restricted maximum likelihood estimation smoothing parameters Comparing week 30°C versus 15°C average temperature prevalence 35 higher diarrhea 73 higher Shiga toxinproducing Escherichia coli STEC 173 higher enterotoxigenic E coli ETEC 80 higher Cryptosporidium Abovemedian weekly precipitation median 13mm range 0396mm associated 29 higher diarrhea adjusted prevalence ratio 129 95 CI 107 155 higher Cryptosporidium ETEC STEC Shigella Campylobacter Aeromonas adenovirus 4041 lower Giardia sapovirus norovirus prevalence association weak null Higher temperature precipitation associated higher prevalence diarrhea multiple enteropathogens higher precipitation associated lower prevalence enteric viruses finding emphasize heterogeneity relationship hydrometeorological variable specific enteropathogens masked looking composite measure like allcause diarrhea result suggest preventive intervention targeted reduce enteropathogens rainy season may effectively reduce child diarrhea enteric pathogen carriage rural Bangladesh setting similar meteorological characteristics infrastructure enteropathogen transmission",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Diarrhea",
            "Infant",
            "Child, Preschool",
            "Risk Factors",
            "Rural Population",
            "Prevalence",
            "Male",
            "Female",
            "Weather",
            "Enterotoxigenic Escherichia coli",
            "Cryptosporidium",
            "Temperature",
            "Shiga-Toxigenic Escherichia coli",
            "Climate Change",
            "Cryptosporidiosis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38739632/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38728310",
        "title": "The PreQuine Platform: A novel diagnostic tool for measuring glucose-6-phosphate dehydrogenase (G6PD) activity and hemoglobin concentration.",
        "abstract": "Quantitative diagnosis glucose6phosphate dehydrogenase G6PD deficiency essential safe administration 8aminoquinoline based radical cure treatment Plasmodium vivax infections Here present PreQuine Platform IVDS USA quantitative biosensor us dualanalyte assay simultaneous measurement Hemoglobin Hgb level G6PD enzyme activity within sample platform relies downloadable mobile application device requires 10μl whole blood work reflectancebased meter Comparing G6PD measurement normalized Hgb 12 sample PreQuine Platform reference measurement method spectrophotometry Pointe Scientific USA hemoglobin meter HemoCue Sweden showed positive significant agreement slope 10091 intercept 00379 laboratory conditions Next step conduct field trial Bangladesh Cambodia USA assess diagnostic performance user friendliness acceptance",
        "mesh_terms": [
            "Humans",
            "Glucosephosphate Dehydrogenase",
            "Glucosephosphate Dehydrogenase Deficiency",
            "Hemoglobins",
            "Biosensing Techniques",
            "Malaria, Vivax",
            "Aminoquinolines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38728310/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38632912",
        "title": "Predicting malaria outbreaks using earth observation measurements and spatiotemporal deep learning modelling: a South Asian case study from 2000 to 2017.",
        "abstract": "Malaria remains one leading communicable cause death Approximately half worlds population considered risk infection predominantly African South Asian countries Although malaria preventable heterogeneity sociodemographic environmental risk factor time across diverse geographical climatological region make outbreak prediction challenging Datadriven approach accounting spatiotemporal variability could offer potential locationspecific early warning tool malaria case study developed internally validated data fusion approach predict malaria incidence Pakistan India Bangladesh using georeferenced environmental factors 200017 districtlevel malaria incidence rate country obtained US Agency International Developments Demographic Health Survey datasets Environmental factor included average annual temperature rainfall normalised difference vegetation index obtained Advancing Research Nutrition Agriculture known AReNA project conducted International Food Policy Research Institute 2020 Data nighttime light intensity derived two satellite National Oceanic Atmospheric Administration Defense Meteorological Satellite ProgramOperational Linescan System Nighttime Lights Time Series Version 4 VIIRS Nighttime DayNight Band Composites version 1 multidimensional spatiotemporal long shortterm memory MLSTM model developed using data 200016 internally validated year 2017 MLSTM model consisted four hidden layers 100 LSTM units fully connected layer used followed linear regression predict malaria incidence rate 2017 using spatiotemporal partitioning Model performance measured using accuracy root mean squared error Countryspecific model produced Bangladesh India Pakistan Bivariate geospatial heatmaps produced qualitative comparison univariate environmental factor malaria rates Malaria incidence predicted 80·6 accuracy district across Pakistan 76·7 district across India 99·1 district across Bangladesh root mean squared error 7 × 10sup4sup Pakistan 4·86 × 10sup6sup India 1·32 × 10sup5sup Bangladesh Bivariate map showed inverse relationship nighttime light malaria rates whereas high malaria rate found area high temperature rainfall vegetation Malaria outbreak could forecasted using remotely measured environmental factors Modelling technique enable simultaneously forecasting ahead time well across large geographical area might potentially empower regional decision maker manage outbreak early NIHR Oxford Biomedical Research Centre Programme Higher Education Commission Pakistan",
        "mesh_terms": [
            "Humans",
            "Deep Learning",
            "Malaria",
            "Incidence",
            "Temperature",
            "Disease Outbreaks"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38632912/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38630832",
        "title": "Perceived needs of disease vector control programs: A review and synthesis of (sub)national assessments from South Asia and the Middle East.",
        "abstract": "Systems disease vector control effective efficient flexible able tackle contemporary challenge threat control elimination vectorborne diseases priority activity towards strengthening vector control systems advocated country conduct vectorcontrol need assessment review carried perceived need disease vector control program among eleven country subnational state South Asia Middle East country state independent team conducted vector control need assessment engagement stakeholders Important weakness described malaria dengue leishmaniases regarding vector surveillance insecticide susceptibility testing monitoring evaluation operations entomological capacity laboratory infrastructure addition community mobilization intersectoral collaboration showed important gaps Countries state expressed concern insecticide resistance could reduce continued effectiveness interventions demand improved monitoring Moreover attainment disease elimination necessitates enhanced vector surveillance Vector control need assessment provided useful planning tool systematic strengthening vector control systems limitation conducting vector control need assessment time resourceintensive increase feasibility utility national assessments abridged version guidance focus operationally relevant topic assessment Similar review needed region different contextual conditions",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Asia, Southern",
            "Dengue",
            "Disease Vectors",
            "Insecticides",
            "Malaria",
            "Middle East",
            "Needs Assessment",
            "Vector Borne Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38630832/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38582094",
        "title": "Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.",
        "abstract": "Regular detailed reporting population health underlying cause death fundamental public health decision making Causespecific estimate mortality subsequent effect life expectancy worldwide valuable metric gauge progress reducing mortality rates estimate particularly important following largescale mortality spikes COVID19 pandemic systematically analysed mortality rate life expectancy allow comparison consequence cause death globally time providing nuanced understanding effect cause global populations Global Burden Diseases Injuries Risk Factors Study GBD 2021 causeofdeath analysis estimated mortality year life lost YLLs 288 cause death agesexlocationyear 204 country territory 811 subnational location year 1990 2021 analysis used 56 604 data sources including data vital registration verbal autopsy well surveys censuses surveillance systems cancer registries among others previous GBD rounds causespecific death rate cause estimated using Cause Death Ensemble modela modelling tool developed GBD assess outofsample predictive validity different statistical model covariate permutation combine result produce causespecific mortality estimateswith alternative strategy adapted model cause insufficient data substantial change reporting study period unusual epidemiology YLLs computed product number death causeagesexlocationyear standard life expectancy age part modelling process uncertainty interval UIs generated using 2·5th 97·5th percentile 1000draw distribution metric decomposed life expectancy cause death location year show causespecific effect life expectancy 1990 2021 also used coefficient variation fraction population affected 90 death highlight concentration mortality Findings reported count agestandardised rates Methodological improvement causeofdeath estimate GBD 2021 include expansion under5years age group include four new age groups enhanced method account stochastic variation sparse data inclusion COVID19 pandemicrelated mortalitywhich includes excess mortality associated pandemic excluding COVID19 lower respiratory infections measles malaria pertussis analysis 199 new countryyears vital registration causeofdeath data 5 countryyears surveillance data 21 countryyears verbal autopsy data 94 countryyears data type added used previous GBD rounds leading cause agestandardised death globally 2019 1990 descending order were ischaemic heart disease stroke chronic obstructive pulmonary disease lower respiratory infections 2021 however COVID19 replaced stroke secondleading agestandardised cause death 94·0 death 95 UI 89·2100·0 per 100 000 population COVID19 pandemic shifted ranking leading five causes lowering stroke thirdleading chronic obstructive pulmonary disease fourthleading position 2021 highest agestandardised death rate COVID19 occurred subSaharan Africa 271·0 death 250·1290·7 per 100 000 population Latin America Caribbean 195·4 death 182·1211·4 per 100 000 population lowest agestandardised death rate COVID19 highincome superregion 48·1 death 47·448·8 per 100 000 population southeast Asia east Asia Oceania 23·2 death 16·337·2 per 100 000 population Globally life expectancy steadily improved 1990 2019 18 22 investigated causes Decomposition global regional life expectancy showed positive effect reduction death enteric infections lower respiratory infections stroke neonatal deaths among others contributed improved survival study period However net reduction 1·6 year occurred global life expectancy 2019 2021 primarily due increased death rate COVID19 pandemicrelated mortality Life expectancy highly variable superregions study period southeast Asia east Asia Oceania gaining 8·3 year 6·79·9 overall smallest reduction life expectancy due COVID19 0·4 years largest reduction life expectancy due COVID19 occurred Latin America Caribbean 3·6 years Additionally 53 288 cause death highly concentrated location less 50 global population 2021 cause death became progressively concentrated since 1990 44 cause showed pattern concentration phenomenon discussed heuristically respect enteric lower respiratory infections malaria HIVAIDS neonatal disorders tuberculosis measles Longstanding gain life expectancy reduction many leading cause death disrupted COVID19 pandemic adverse effect spread unevenly among populations Despite pandemic continued progress combatting several notable cause death leading improved global life expectancy study period seven GBD superregions showed overall improvement 1990 2021 obscuring negative effect year pandemic Additionally finding regarding regional variation cause death driving increase life expectancy hold clear policy utility Analyses shifting mortality trend reveal several causes widespread globally increasingly concentrated geographically change mortality concentration alongside investigation changing risks interventions relevant policy present important opportunity deepen understanding mortalityreduction strategies Examining pattern mortality concentration might reveal area successful public health intervention implemented Translating success location certain cause death remain entrenched inform policy work improve life expectancy people everywhere Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Humans",
            "Life Expectancy",
            "Cause of Death",
            "Global Burden of Disease",
            "Female",
            "COVID-19",
            "Male",
            "Aged",
            "Middle Aged",
            "Adult",
            "Child, Preschool",
            "Infant",
            "Global Health",
            "Adolescent",
            "Young Adult",
            "Child",
            "Aged, 80 and over",
            "SARS-CoV-2",
            "Infant, Newborn",
            "Pandemics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38582094/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38521526",
        "title": "Defining the hidden burden of disease in rural communities in Bangladesh, Cambodia and Thailand: a cross-sectional household health survey protocol.",
        "abstract": "lowincome middleincome country Southeast Asia burden disease among rural population remains poorly understood posing challenge effective healthcare prioritisation resource allocation Addressing knowledge gap South Southeast Asia Communitybased Trials Network SEACTN undertake survey aim determine prevalence wide range noncommunicable communicable diseases one key initiative first projectthe Rural Febrile Illness project RFI survey alongside RFI study explore fever aetiology leading cause mortality establishing village health facility map profiles provide updated epidemiological background rural area network operational 20222023 crosssectional household survey conducted across three SEACTN site Bangladesh Cambodia Thailand Using twostage clustersampling approach employ probabilityproportionaltosize sample method village simple random sample household selection enrolling member selected households Approximately 1500 participant enrolled per country Participants undergo questionnaire interview physical examination haemoglobin pointofcare testing Blood sample collected sent central laboratory test chronic acute infections biomarkers associated cardiovascular disease diabetes Prevalences presented overall estimate country stratified compared across site participants sociodemographic characteristics Associations disease status risk factor characteristic explored study protocol approved Oxford Tropical Research Ethics Committee National Research Ethics Committee Bangladesh Medical Research Council Cambodian National Ethics Committee Health Research Chiang Rai Provincial Public Health Research Ethical Committee result disseminated via local health authority partners peerreviewed journal conference presentations NCT05389540",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Cambodia",
            "Cost of Illness",
            "Cross-Sectional Studies",
            "Health Surveys",
            "Rural Population",
            "Thailand"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38521526/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38512855",
        "title": "Prevalence of unqualified sources of antimalarial drug prescription for children under the age of five: A study in 19 low- and middle-income countries.",
        "abstract": "Antimalarial drug resistance pose severe danger global health Low MiddleIncome Countries LMICs lack reliable information antimalarial prescription recent malarial fever child five study aim determine prevalence unqualified source antimalarial drug prescription child age five 19 low middleincome countries performed crosssectional study Malaria Indicator Survey MIS datasets n  106265 across 19 LMICs recent MIS datasets used study included child five taken antimalarial drug recent malarial fever outcome variable classified two distinct categories taken antimalarial drug malarial fever qualified source not Among LMICs found 871 child five received antimalarial prescription unqualified source recently experienced malarial fever several LMICs Tanzania Nigeria Ghana substantial portion recent antimalarial prescription malaria taken unqualified source about 60 LMICs Guinea 318 Mali 313 Nigeria 204 Kenya 26 Senegal 27 low rate antimalarial drug consumption even though child five received high percentage antimalarial prescription qualified source recent malarial fever Living rural areas mother higher education parent wealth frequently taken antimalarial qualified source recent malarial fever child five across LMICs study draw attention importance national local level preventative strategy across LMICs restrict antimalarial drug consumption antimalarial prescription unqualified source recent malarial fever child five shockingly high LMICs high rate unqualified prescription certain LMICs",
        "mesh_terms": [
            "Child",
            "Female",
            "Humans",
            "Antimalarials",
            "Developing Countries",
            "Cross-Sectional Studies",
            "Prevalence",
            "Malaria",
            "Drug Prescriptions"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38512855/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38510530",
        "title": "A Systematic Literature Review of Mathematical Models for Coinfections: Tuberculosis, Malaria, and HIV/AIDS.",
        "abstract": "Tuberculosis malaria HIV among lethal diseases AIDS Acquired Immune Deficiency Syndrome chronic potentially lifethreatening condition caused human immunodeficiency virus HIV Individually infection present significant health challenge However tuberculosis malaria HIV cooccur symptom worsen leading increased mortality risk Mathematical model created study coinfections involving tuberculosis malaria HIV systematic literature review explores importance coinfection model examining article reputable database Dimensions ScienceDirect Scopus PubMed primary emphasis investigating coinfection model related tuberculosis malaria HIV finding demonstrate article thoroughly cover various aspects including model development mathematical analysis sensitivity analysis optimal control strategies research discoveries Based comprehensive evaluation offer valuable recommendation future research effort field",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38510530/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38483975",
        "title": "Mathematical models of Plasmodium vivax transmission: A scoping review.",
        "abstract": "Plasmodium vivax one geographically widespread malaria parasite world primarily found across SouthEast Asia Latin America part Africa One significant characteristic P vivax parasite ability remain dormant human liver hypnozoites subsequently reactivate initial infection ie relapse infections Mathematical modelling approach widely applied understand P vivax dynamic predict impact intervention outcomes Models capture P vivax dynamic differ capture P falciparum dynamics must account relapse caused activation hypnozoites article provide scoping review mathematical model capture P vivax transmission dynamic published January 1988 May 2023 primary objective work provide comprehensive summary mathematical model technique used model P vivax dynamics so aim assist researcher working mathematical epidemiology disease transmission aspect P vivax malaria highlighting best practice currently published model highlighting model development required categorise P vivax model according whether deterministic agentbased approach used provide overview different strategy used incorporate parasites biology use multiple scale withinhost populationlevel superinfection immunity treatment interventions published literature rationale different modelling approach driven research question hand model focus parasites complicated biology others incorporate simplified assumption avoid model complexity Overall existing literature mathematical model P vivax encompasses various aspect parasites dynamics recommend future research focus refining key aspect P vivax dynamic modelled including spatial heterogeneity exposure risk heterogeneity susceptibility infection accumulation hypnozoite variation interaction P falciparum P vivax acquisition immunity recovery superinfection",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Plasmodium vivax",
            "Superinfection",
            "Malaria, Vivax",
            "Malaria",
            "Models, Theoretical",
            "Malaria, Falciparum",
            "Parasites",
            "Recurrence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38483975/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38431444",
        "title": "Safety and immunogenicity of Innovax bivalent human papillomavirus vaccine in girls 9-14 years of age: Interim analysis from a phase 3 clinical trial.",
        "abstract": "World Health Organization human papillomavirus HPV vaccination recommendation include single twodose schedule individual 920 year old advice generating data singledose efficacy immunobridging ongoing Phase 3 trial Innovaxs bivalent types 16 18 HPV vaccine Cecolin® assesses low middleincome country alternative dosing schedule generates data following one dose girl 914 year old Interim data 6month dosing group presented Bangladesh Ghana 1025 girl randomized receive either two dos Cecolin 6 12 24month intervals one dose Gardasil® followed one dose Cecolin month 24 two dos Gardasil 6 month apart referent Serology measured enzymelinked immunosorbent assay ELISA and subset neutralization assays Primary objective include immunological noninferiority Cecolin schedule referent one month second dose Safety endpoint include reactogenicity unsolicited adverse event 7 30 day postvaccination respectively well serious adverse event throughout study Interim analysis included data two group 0 6month schedule 205 participant per group One month Dose 2 100 participant seropositive ELISA seroconverted antigens Noninferiority Cecolin Gardasil demonstrated Six month following one dose 96 participant seropositive ELISA HPV antigens trend higher geometric mean concentration following Cecolin administration Reactogenicity safety comparable vaccines Cecolin 0 6month schedule elicits robust immunogenicity Noninferiority Gardasil demonstrated one month 0 6month schedule Immunogenicity following one dose comparable Gardasil six months vaccine safe well tolerated ClinicalTrialsgov No 04508309",
        "mesh_terms": [
            "Female",
            "Humans",
            "Child",
            "Adolescent",
            "Young Adult",
            "Adult",
            "Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18",
            "Papillomavirus Infections",
            "Antibodies, Viral",
            "Papillomavirus Vaccines",
            "Vaccination",
            "Immunogenicity, Vaccine"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38431444/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38361888",
        "title": "Evaluation of changes in the cognitive, affective, and psychomotor domains of learning following an interprofessional intervention for malaria and its control among the Bedia tribe, a particularly vulnerable tribal group, in rural Eastern India.",
        "abstract": "Bedia tribal people found India poor illiterate confined culturally many part India malaria disease caused mosquitoes becoming common Raising awareness educating people best method stop disease maintain good health study aimed determine perception attitudes practice particularly vulnerable tribal groupthe Bediain rural region eastern India questionnaire 19 structured question created Bedia participant received questionnaire us already responded intervention took form several health education workshop created response deficiency identified pretest assessments replies identical questionnaire used pretest evaluation given participant posttest attended training sessions current study found first cognitive domain question malaria transmission statistically significant change malaria breeding grounds region higher mosquito numbers source information malaria are knowledge treatment malaria agent used treat statistically significant current study fifth question common symptom malaria statistically significant answer question What see someone suffering malaria How much time spent malaria control program Malaria detection Regular usage bednets affective psychomotor domain statistical significance research intervention raise awareness malaria tribal region northern West Bengal eastern India bordering Bangladesh published first time knowledge majority item cognitive psychomotor affective learning domains seen significant changes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38361888/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38361592",
        "title": "Monitoring and evaluation practices and operational research during public health emergencies in southeast Asia region (2012-2022) - a systematic review.",
        "abstract": "systematic review aimed explore monitoring evaluation ME operational research OR practice public health emergency PHE southeast Asian region SEAR last decade searched electronic database grey literature source study published 2012 2022 study written English included narrative synthesis undertaken total 29 study included review Among 25 study documented ME four study documented practices majority study India Bangladesh evidence found Sri Lanka Bhutan Myanmar TimorLeste ME surveillance program identified among PHE due COVID19 prevalent ME conducted response COVID19 cholera Nipah Ebola iCandida aurisi hepatitis A practice minimal reported India Indonesia India conducted COVID19 malaria whereas Indonesia focused COVID19 influenza SEAR country mechanism conducting ME noticeable limitation practices compelling need develop standard framework ME Additionally enhancing private sector engagement crucial strengthening preparedness PHE Furthermore necessity increase awareness importance conducting ME PHE",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38361592/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38313152",
        "title": "Evaluating global health initiatives to improve health equity.",
        "abstract": "",
        "mesh_terms": [
            "Humans",
            "Health Equity",
            "Global Health",
            "Health Policy",
            "Health Status Disparities"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38313152/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38290664",
        "title": "Burden of child mortality from malaria in high endemic areas: Results from the CHAMPS network using minimally invasive tissue sampling.",
        "abstract": "Malaria leading cause childhood mortality worldwide However accurate estimate malaria prevalence causality among patient die country level lacking due limited specificity diagnostic tool used attribute etiologies Accurate estimate crucial prioritizing intervention resource aimed reducing malariarelated mortality Seven Child Health Mortality Prevention Surveillance CHAMPS Network site collected comprehensive data stillbirth child 5 years using minimally invasive tissue sampling MITS DeCoDe Determination Cause Death panel employed standardized protocol assigning underlying intermediate immediate cause death integrating sociodemographic clinical laboratory including extensive microbiology histopathology malaria testing verbal autopsy data Analyses conducted ascertain strength evidence cause death CoD describe factor associated malariarelated deaths estimate malariaspecific mortality assess proportion preventable deaths December 3 2016 December 31 2022 2673 death underwent MITS CoD attributed four CHAMPS site least 1 malariaattributed death malariaattributable death documented among 891 stillbirth 924 neonatal deaths therefore analysis concentrate remaining 858 death among child aged 159 months Malaria causal chain 429 126294 death Sierra Leone 314 96306 Kenya 182 36198 Mozambique 67 460 Mali 03 1292 South Africa Compared nonmalaria related deaths malariarelated death skewed towards older infant child p  0001 710 among age 1259 months Malaria sole infecting pathogen 184 702 malariaattributed deaths whereas bacterial viral coinfections identified causal pathway 24·0 122 cases respectively Malnutrition found similar level causal pathway malaria 267 nonmalaria 307 p  0256 deaths Less twothirds 164262 626 malaria death received antimalarial prior death Nearly 98·9 malariarelated death deemed preventable Malaria remains significant cause childhood mortality CHAMPS malariaendemic sites high bacterial coinfection prevalence among malaria death underscore potential benefit antibiotic severe malaria patients Compared nonmalaria deaths many malariaattributed death preventable accessible malaria control measures",
        "mesh_terms": [
            "Infant",
            "Child",
            "Infant, Newborn",
            "Female",
            "Pregnancy",
            "Humans",
            "Child Mortality",
            "Stillbirth",
            "Child Health",
            "Cause of Death",
            "Malaria"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38290664/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38257964",
        "title": "Detection of Developmental Asexual Stage-Specific RNA Editing Events in <i>Plasmodium falciparum</i> 3D7 Malaria Parasite.",
        "abstract": "Transcriptional variation studied posttranscriptional modification due RNA editing investigated iPlasmodiumi investigated developmental stagespecific RNA editing selected gene iPlasmodium falciparumi 3D7 detected extensive amination deaminationtype RNA editing 8 16 24 32 40 46 h tightly synchronized iPlasmodiumi editing event observed 8 16 h ringstage parasites Extensive AtoG deaminationtype editing detected 16 h ring stage 25 8 h ring stage 20 Extensive UtoC aminationtype editing detected 16 h ring stage 31 8 h ring stage 22 28S rRNA editing converted loop structure stem structure hemoglobin binding activity PF3D70216900 also altered due RNA editing Among expressed 28S rRNA genes PF3D70532000 PF3D70726000 expression higher Increased amount transcript two gene found particularly PF3D70726000 ring stage PF3D70532000 trophozoite schizont stages Adenosine deaminase ADA expression correlate editing level first experimental report RNA editing help identify editing machinery might useful antimalarial drug discovery malaria control",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38257964/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38234878",
        "title": "Effects of healthcare spending on public health status: An empirical investigation from Bangladesh.",
        "abstract": "escalation healthcare spending many nations particularly emerging country Bangladesh may largely attributed growing demand healthcare services Evidently significant expansion public funding allocated health sector Bangladesh intending enhance health outcomes Therefore purpose study examine impact healthcare expenditure health outcomes specifically focusing reduction different mortality rate transmission various infectious diseases total 30 year data 19902019 health sector Bangladesh collected different national international sources Vector Autoregression Exogenous Variables VARX model employed determine effect healthcare expenditure health outcomes Results revealed per caput health expenditure number doctor showed significant positive impact life expectancy maternal child health Also governments annual budget health sector number doctor significant positive impact lowering death Diphtheria Cholera Tuberculosis Malaria diseases order develop sustainable healthcare system within nation imperative government prioritize allocation sufficient effective healthcare funding cater need populace",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38234878/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38214911",
        "title": "Predicting the potential impact of scaling up four pneumonia interventions on under-five pneumonia mortality: A prospective Lives Saved Tool (LiST) analysis for Bangladesh, Chad, and Ethiopia.",
        "abstract": "Pneumonia remains leading cause mortality underfive child outside neonatal period Progress slowed last decade necessitating increased effort scale effective pneumonia interventions used Lives Saved Tool LiST modelling software child mortality low middleincome settings prospectively analyse potential impact upscaling pneumonia intervention Bangladesh Chad Ethiopia 2023 2030 included Haemophilus influenzae type B Hib vaccination pneumococcal conjugate vaccine PCV oral antibiotics pulse oximetry oxygen pneumonia intervention analysis Outcomes interest number pneumonia death averted proportion death averted intervention change underfive mortality rate found 19 775 life child underfive could saved Bangladesh 76 470 Chad 97 343 Ethiopia scaling intervention coverage ≥90 2030 estimated reduction pneumonia death among child five range 4461 5791 respective countries Increased coverage oral antibiotics pulse oximetry oxygen show similar effect three countries averting 1880 2365 expected pneumonia deaths Scalingup PCV prominent effect especially Chad could avert 1404 expected pneumonia deaths Underfive mortality could reduced 142 per 1000 live birth Bangladesh 2252 per 1000 live birth Chad 548 per 1000 live birth Ethiopia analysis show high impact upscaling pneumonia interventions lack data regarding coverage indicator barrier research policy implementation requiring increased attention",
        "mesh_terms": [
            "Child",
            "Infant, Newborn",
            "Humans",
            "Infant",
            "Ethiopia",
            "Bangladesh",
            "Chad",
            "Prospective Studies",
            "Pneumonia",
            "Oxygen",
            "Vaccines, Conjugate",
            "Anti-Bacterial Agents"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38214911/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38158245",
        "title": "Infections and Acute Kidney Injury: A Global Perspective.",
        "abstract": "Globally estimated 133 million case acute kidney injury AKI annually Although infection common cause AKI globally infectionassociated AKI occurs low lowermiddleincome countries marked difference etiology infectionassociated AKI across age groups population risk geographic location article provides global overview different infection associated commonly AKI including severe acute respiratory syndrome coronavirus 2 SARSCoV2 human immunodeficiency virus malaria dengue leptospirosis tickborne illnesses viral hemorrhagic fevers discussion focus infectious condition associated AKI including sepsis diarrheal disease pregnancy peripartum neonatal AKI article also discusses future infectionassociated AKI framework climate change explores increased investment achieving sustainable development goal may contribute International Society Nephrologys 0 25 objective curtail avoidable AKIrelated fatality 2025",
        "mesh_terms": [
            "Female",
            "Pregnancy",
            "Infant, Newborn",
            "Humans",
            "Acute Kidney Injury",
            "SARS-CoV-2",
            "Malaria",
            "Risk Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38158245/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38133277",
        "title": "Adherence to Anti-Malarial Treatment in Malaria Endemic Areas of Bangladesh.",
        "abstract": "Ensuring adherence antimalarial treatment crucial achieving radical cure elimination malaria especially hardtoreach areas conducted study assess current scenario drug adherence four endemic subdistricts Bangladesh Among 110 enrolled participants 70 monoinfected iPlasmodium falciparumi remaining 30 iP vivaxi overall treatment adherence frequency 927 95 CI 830963 total eight participant found nonadherent treatment Bandarban Level nonadherence equally observed two age groups 1117 18 years However male participant ini  6 found nonadherent female ini  2 Among 73 nonadherence treatment single participant iP falciparumi monoinfection refused take medication became nonadherent Remaining participant stated feeling well going work thus leaving treatment course uncompleted Although overall compliance malaria medication seems good gradual increase noncompliance iP vivaxi malaria treatment suggests National Malaria Elimination Program must enhanced monitored fulfil projected malaria elimination goal 2030 Bangladesh",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38133277/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38123228",
        "title": "Safety and efficacy of primaquine in patients with <i>Plasmodium vivax</i> malaria from South Asia: a systematic review and individual patient data meta-analysis.",
        "abstract": "optimal dosing primaquine prevent relapsing iPlasmodium vivaxi malaria South Asia remains unclear investigated efficacy safety different primaquine regimen prevent iP vivaxi relapse systematic review identified iP vivaxi efficacy study South Asia published 1 January 2000 23 August 2021 onestage metaanalysis available individual patient data cumulative risk iP vivaxi recurrence day 42 180 assessed primaquine total mgkg dose duration risk recurrence day 180 also determined twostage metaanalysis Patients 25 drop haemoglobin 70 gL absolute drop 50 gL day 1 14 categorised daily mgkg primaquine dose 791 patient 7 study onestage metaanalysis day 180 cumulative risk recurrence 611 95 CI 422 804 201 patients 25 recurrences treatment without primaquine 288 95 CI 82 741 398 patients 4 recurrences following low total 2 5 mgkg 0 96 patients 0 recurrences following high total dose primaquine ≥5 mgkg subsequent twostage metaanalysis nine study 3529 patients pooled proportion iP vivaxi recurrence day 180 121 95 CI 77 172 23 95 CI 03 54 07 95 CI 0 61 respectively patient 25 drop haemoglobin 70 gL Primaquine treatment led marked decrease iP vivaxi recurrence following low 35 mgkg high 7 mgkg total doses reported severe haemolytic events CRD42022313730",
        "mesh_terms": [
            "Humans",
            "Primaquine",
            "Malaria, Vivax",
            "Antimalarials",
            "Plasmodium vivax",
            "Recurrence",
            "Asia, Southern",
            "Hemoglobins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38123228/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38092509",
        "title": "Global Burden of Cardiovascular Diseases and Risks, 1990-2022.",
        "abstract": "",
        "mesh_terms": [
            "Humans",
            "Cardiovascular Diseases",
            "Risk Factors",
            "Environmental Exposure",
            "Global Health",
            "Quality-Adjusted Life Years"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38092509/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38081771",
        "title": "Ethical and cultural implications for conducting verbal autopsies in South and Southeast Asia: a qualitative study.",
        "abstract": "Causes death often go unrecorded lower income countries yet information critical Verbal autopsy questionnaire interview family member caregiver elicit symptom circumstance preceding death assign probable cause social cultural aspect verbal autopsy gotten less attention technical aspect widely explored South Southeast Asia settings October 2021 March 2023 prior implementing verbal autopsy study rural site Bangladesh Cambodia Laos Myanmar Thailand focus group discussion conducted village heads religious leader community member varied demographic backgrounds Thematic analysis elucidated custom traditional view surrounding death understand local ethnocultural sensitivities found death ritual varied greatly among religions ethnicity socioeconomic status Mourning period reported last 3100 day related cause death age close deceased person family Participants advised interview happen mourning period avoid emotional distress long avoid recall bias Interviewers introduced respondent trusted local person provide reassurance confidentiality familys residence preferred interview location Interview question require careful local language translation community sensitisation important data collection Verbal autopsy acceptable across wide range cultural setting Southeast Asia provided local norm preidentified followed",
        "mesh_terms": [
            "Humans",
            "Cause of Death",
            "Autopsy",
            "Family",
            "Surveys and Questionnaires",
            "Asia, Southeastern"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38081771/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38059069",
        "title": "Efficient Malaria Parasite Detection From Diverse Images of Thick Blood Smears for Cross-Regional Model Accuracy.",
        "abstract": "iGoali purpose work improve malaria diagnosis efficiency integrating smartphones microscopes integration involves image acquisition algorithmic detection malaria parasite various thick blood smear TBS datasets sourced different global regions including lowquality image SubSaharan Africa iMethodsi approach combine image segmentation convolutional neural network CNN distinguish white blood cells artifacts malaria parasites portable system integrates microscope graphical user interface facilitate rapid malaria detection smartphone images trained CNN model using opensource data Chittagong Medical College Hospital Bangladesh iResultsi validation process using microscopic TBS training dataset additional dataset SubSaharan Africa demonstrated proposed model achieved accuracy 9774 ± 005 F1score 9775 ± 004 Remarkably proposed model AlexNet surpasses reported literature performance 9632 iConclusionsi algorithm show promise aiding malariastricken regions especially limited resources",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38059069/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38049847",
        "title": "Examining the disparities of anti-malarial drug consumption among children under the age of five: a study of 5 malaria-endemic countries.",
        "abstract": "Malaria one prominent illness affecting children ranking one key development concern many low middleincome country LMICs much information available use antimalarial drug LMICs child five study aimed investigate disparity antimalarial drug consumption malaria among child age five LMICs study used recent available crosssectional data Malaria Indicator Survey MIS datasets across five LMICs Guinea Kenya Mali Nigeria Sierra Leone covered portion subSaharan Africa study carried January 2 2023 April 15 2023 included child age five taken antimalarial drug malaria 2 week survey date outcome variable antimalarial drug consumption classified two groups taken antimalarial drug not study LMICs 32397 child five observed among them 441 received antimalarial drugs five LMICs Kenya lowest 92 Mali highest 705 percentage antimalarial drug consumption Children five malaria likely receive antimalarial drug 1 year old live rural areas mother higher education levels come wealthier families study emphasizes importance developing universal coverage strategy antimalarial drug consumption national local levels study also recommends improving availability access antimalarial drug may necessary consumption drug treating malaria child age five shockingly low LMICs",
        "mesh_terms": [
            "Infant",
            "Female",
            "Humans",
            "Child",
            "Antimalarials",
            "Cross-Sectional Studies",
            "Malaria",
            "Mothers",
            "Kenya"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38049847/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38021035",
        "title": "Addressing antimicrobial resistance through community engagement: a framework for developing contextually relevant and impactful behaviour change interventions.",
        "abstract": "Community engagement CE intervention often explore promote behaviour change around specific challenge Suggestions behaviour change coproduced partnership community facilitate this essential intervention includes key content unpacks challenge interest via multiple source knowledge However community lived experience academic evidence appear misaligned tension appear within coproduction dynamic CE specifically within context antimicrobial resistance AMR ideal behaviour often superseded practical possible particular community context describe framework equitable development contextually appropriate clearly evidenced behavioural objective CE interventions framework explores different source knowledge AMR including potentially competing view different stakeholders framework allows key content AMR selected based upon academic evidence contextual appropriateness fit chosen CE approach case study framework action exemplifies framework applicable range contexts CE approach One Health topic beyond AMR Within CE interventions academic evidence crucial develop wellinformed key content However formative work also involve community members ensuring contextual knowledge valued type CE approach also need careful consideration methodological constraint may limit breadth depth information delivered within intervention thus scope key content",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38021035/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37979594",
        "title": "Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial.",
        "abstract": "area coendemic Plasmodium vivax Plasmodium falciparum increased risk P vivax parasitaemia following P falciparum malaria Radical cure currently recommended patient presenting P vivax malaria Expanding indication radical cure patient presenting P falciparum malaria could reduce risk subsequent P vivax parasitaemia multicentre openlabel superiority randomised controlled trial five health clinic Bangladesh Indonesia Ethiopia Bangladesh Indonesia patient excluded younger 1 year whereas Ethiopia patient excluded younger 18 years Patients uncomplicated P falciparum monoinfection fever history fever 48 h preceding clinic visit eligible enrolment required glucose6dehydrogenase G6PD activity 70 greater Patients received blood schizontocidal treatment artemetherlumefantrine Ethiopia Bangladesh dihydroartemisininpiperaquine Indonesia randomly assigned 11 receive either highdose shortcourse oral primaquine intervention arm total dose 7 mgkg 7 days standard care standard care arm single dose oral primaquine 0·25 mgkg Random assignment done independent statistician block eight use sealed envelopes randomly assigned eligible patient included primary safety analyses perprotocol analysis excluded complete treatment substantial protocol violations primary endpoint incidence risk P vivax parasitaemia day 63 trial registered ClinicalTrialsgov NCT03916003 Aug 18 2019 March 14 2022 total 500 patient enrolled randomly assigned 495 eligible patient included intentiontotreat analysis 246 intervention 249 control incidence risk P vivax parasitaemia day 63 11·0 95 CI 7·515·9 standard care arm compared 2·5 1·05·9 intervention arm hazard ratio 0·20 95 CI 0·080·51 p0·0009 effect size differed blood schizontocidal treatment site Routine symptom reporting day 2 day 7 similar groups first 42 days total four primaquinerelated adverse event reported standard care arm 26 intervention arm 132 92 143 adverse event mild two serious adverse event intervention arm considered unrelated study drug None patient developed severe anaemia defined haemoglobin 5 gdL patient G6PD activity 70 greater highdose shortcourse primaquine safe relatively well tolerated reduced risk subsequent P vivax parasitaemia within 63 day five fold Universal radical cure therefore potentially offer substantial clinical public health operational benefits benefit vary endemic setting Australian Academy Science Regional Collaborations Program Bill  Melinda Gates Foundation National Health Medical Research Council",
        "mesh_terms": [
            "Humans",
            "Primaquine",
            "Antimalarials",
            "Plasmodium vivax",
            "Artemether",
            "Artemether, Lumefantrine Drug Combination",
            "Australia",
            "Malaria, Falciparum",
            "Malaria, Vivax",
            "Malaria",
            "Plasmodium falciparum",
            "Parasitemia"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37979594/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37977174",
        "title": "The 2023 report of the Lancet Countdown on health and climate change: the imperative for a health-centred response in a world facing irreversible harms.",
        "abstract": "iLanceti Countdown international research collaboration independently monitor evolving impact climate change health emerging health opportunity climate action eighth iteration 2023 report draw expertise 114 scientist health practitioner 52 research institution UN agency worldwide provide comprehensive assessment yet 2022 iLanceti Countdown warned people’s health mercy fossil fuel stressed transformative opportunity jointly tackling concurrent climate change energy costofliving health crisis human health wellbeing year’s report find sign progress current 10year mean heating 1·14°C preindustrial levels climate change increasingly impacting health survival people worldwide projection show risk could worsen steeply inaction However health matter gaining prominence climate change negotiations report highlight new opportunity deliver healthpromoting climate change action safe thriving future all 2023 world saw highest global temperature 100 000 years heat record broken continent 2022 Adults older 65 year infant younger 1 year extreme heat particularly lifethreatening exposed twice many heatwave day would experienced 1986–2005 indicator 112 Harnessing rapidly advancing science detection attribution new analysis show 60 day reached healththreatening high temperature 2020 made twice likely occur due anthropogenic climate change indicator 115 heatrelated death people older 65 year increased 85 compared 1990–2000 substantially higher 38 increase would expected temperature changed indicator 115 Simultaneously climate change damaging natural human system people rely good health global land area affected extreme drought increased 18 1951–60 47 2013–22 indicator 122 jeopardising water security sanitation food production higher frequency heatwaves drought 2021 associated 127 million people experiencing moderate severe food insecurity compared 1981–2010 indicator 14 putting million people risk malnutrition potentially irreversible health effects changing climatic condition also putting population risk lifethreatening infectious diseases dengue malaria vibriosis West Nile virus indicator 13 Compounding direct health impacts economic loss associated global heating increasingly harm livelihoods limit resilience restrict fund available tackle climate change Economic loss extreme weather event increased 23 2010–14 2018–22 amounting US264 billion 2022 alone indicator 411 whereas heat exposure led global potential income loss worth 863 billion indicators 114 413 Labour capacity loss resulting heat exposure affected low medium Human Development Index HDI country most exacerbating global inequities potential income loss equivalent 6·1 3·8 gross domestic product GDP respectively indicator 413 multiple simultaneously rising risk climate change amplifying global health inequity threatening foundation human health Health system increasingly strained 27 surveyed city declared concern health system overwhelmed impact climate change indicator 213 Often due scarce financial resource low technical human capacity country vulnerable climate impact also face challenge achieving adaptation progress reflecting human risk unjust transition 44 low HDI country 54 medium HDI country reported high implementation health emergency management capacity 2022 compared 85 high HDI country indicator 225 Additionally low medium HDI country highest proportion city intending undertake climate change risk assessment 2021 12 indicator 213 inequality aggravated persistent failure wealthiest country deliver promised modest annual sum 100 billion support climate action country defined developing within UN Framework Convention Climate Change Consequently country historically contributed least climate change bearing brunt health impacts—both reflection direct consequence structural inequity lie within root cause climate change growing threat experienced date early sign symptom rapidly changing climate could mean health world’s populations 1337 tonne COsub2sub emitted second moment delay worsens risk people’s health survival year’s report new projection reveal danger delay action every tracked health dimension worsening climate changes global mean temperature continues rise 2°C annual heatrelated death projected increase 370 midcentury assuming substantial progress adaptation indicator 115 scenario heatrelated labour loss projected increase 50 indicator 114 heatwaves alone could lead 524·9 million additional people experiencing moderatetosevere food insecurity 2041–60 aggravating global risk malnutrition Lifethreatening infectious disease also projected spread further length coastline suitable iVibrioi pathogen expanding 17–25 transmission potential dengue increasing 36–37 midcentury risk rise cost challenge adaptation estimate provide indication future could hold However poor accounting nonlinear responses tipping points cascading synergistic interaction could render projection conservative disproportionately increasing threat health population worldwide health risk 2°C hotter world underscore health imperative accelerating climate change action limit adaptation drawing closer ambitious mitigation paramount keep magnitude health hazard within limit capacity health system adapt Yet year scientific warning threat people’s life met grossly insufficient action policy date put world track almost 3°C heating 2022 iLanceti Countdown report highlighted opportunity accelerate transition away healthharming fossil fuel response global energy crisis However data year show world often moving wrong direction Energyrelated COsub2sub emission increased 0·9 record 36·8 Gt 2022 indicator 311 still 9·5 global electricity come modern renewables mainly solar wind energy despite cost falling fossil fuels Concerningly driven partly record profits oil gas company reducing compliance Paris Agreement strategy world’s 20 largest oil gas company early 2023 result emission surpassing level consistent Paris Agreement goal 173 2040—an increase 61 2022 indicator 426 Rather pursuing accelerated development renewable energy fossil fuel company allocated 4 capital investment renewables 2022 Meanwhile global fossil fuel investment increased 10 2022 reaching 1 trillion indicator 421 expansion oil gas extractive activity supported private public financial flows Across 2017–21 40 bank lend fossil fuel sector collectively invested 489 billion annually fossil fuel annual average 52 increasing lending 2010–16 Simultaneously 2020 78 country assessed responsible 93 global COsub2sub emissions still provided net direct fossil fuel subsidy totalling 305 billion hindering fossil fuel phaseout indicator 424 Without rapid response course correct persistent use expansion fossil fuel ensure increasingly inequitable future threatens life billion people alive today Despite challenges data also expose transformative health benefit could come transition zerocarbon future health professional playing crucial role ensuring gain maximised Globally 775 million people still live without electricity close 1 billion people still served healthcare facility without reliable energy structural global inequity development of access to use clean energy 2·3 electricity low HDI country come modern renewables against 11 high HDI countries 92 household low HDI country still rely biomass fuel meet energy need against 7·5 high HDI countries indicator 311 312 context transition renewables enable access decentralised clean energy and coupled intervention increase energy efficiency reduce energy poverty power high quality healthsupportive services reducing burning dirty fuel including fossil fuel biomass intervention could help avoid large proportion 1·9 million death occur annually dirtyfuelderived outdoor airborne fine particulate matter pollution PMsub2·5sub indicator 321 large proportion 78 death per 100 000 people associated exposure indoor air pollution indicator 322 Additionally development renewable energy market generate net employment opportunity safer locally available jobs Ensuring countries particularly facing high level energy poverty supported safe development deployment adoption renewable energy key maximising health gain preventing unjust extractive industrial practice harm health livelihood local population widen health inequities fossil fuel accounting 95 road transport energy indicator 313 intervention enable promote safe active travel zeroemission public transport deliver emission reduction promote health physical activity avert many 460 000 death caused annually transportderived PMsub2·5sub pollution indicator 321 3·2 million annual death related physical inactivity Peoplecentred climateresilient urban redesign improve building energy efficiency increase green blue spaces promote sustainable cooling additionally prevent heatrelated health harms avoid airconditioningderived emission indicator 222 provide direct physical mental health benefits Additionally food system responsible 30 global greenhouse gas GHG emissions 57 agricultural emission 2020 derived production red meat milk indicator 331 Promoting enabling equitable access affordable healthy lowcarbon diet meet local nutritional cultural requirement contribute mitigation preventing many 12·2 million death attributable suboptimal diet indicator 332 health community could play central role securing benefits delivering public health intervention reduce air pollution enabling supporting active travel healthier diets promoting improvement environmental condition commercial activity define health outcomes Importantly health sector lead example transition sustainable resourceefficient netzero emission health systems thereby preventing 4·6 contribution global GHG emissions cascading impact ultimately affecting broader economy indicator 34 encouraging sign progress offer glimpse enormous human benefit healthcentred action could render Deaths attributable fossilfuelderived air pollution decreased 15·7 since 2005 80 reduction result reduced coalderived pollution Meanwhile renewable energy sector expanded historical high 12·7 million employee 2021 indicator 422 renewable energy accounted 90 growth electricity capacity 2022 indicator 311 Supporting this global clean energy investment increased 15 2022 1·6 trillion exceeding fossil fuel investment 61 indicator 421 lending green energy sector rose 498 billion 2021 approaching fossil fuel lending indicator 427 Scientific understanding link health climate change rapidly growing although coverage lag affected regions 3000 scientific article covered topic 2022 indicators 531 532 Meanwhile health dimension climate change increasingly acknowledged public discourse 24 climate change newspaper article 2022 referring health short 26 2020 indicator 51 Importantly international organisation increasingly engaging health cobenefits climate change mitigation indicator 542 government increasingly acknowledge link 95 updated Nationally Determined Contributions NDCs Paris Agreement referring health—up 73 2020 indicator 541 trend signal could start lifesaving transition world currently heading towards 3°C heating delay climate change action increasingly threaten health survival billion people alive today meaningful prioritisation health upcoming international climate change negotiation could offer unprecedented opportunity deliver healthpromoting climate action pave way thriving future However delivering ambition require confronting economic interest fossil fuel healthharming industries delivering sciencegrounded steadfast meaningful sustained progress shift away fossil fuels accelerate mitigation deliver adaptation health Unless progress materialises growing emphasis health within climate change negotiation risk mere healthwashing increasing acceptability initiative minimally advance action ultimately undermine—rather protect—the future people alive today generation come Safeguarding people’s health climate policy require leadership integrity commitment health community sciencedriven approach community uniquely positioned ensure decision maker held accountable foster humancentred climate action safeguard human health else ambition Paris Agreement still achievable prosperous healthy future still lie within reach concerted effort commitment health professionals policy makers corporations financial institution needed ensure promise healthcentred climate action becomes reality delivers thriving future all",
        "mesh_terms": [
            "Humans",
            "Climate Change",
            "Public Health",
            "Global Health"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37977174/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37890672",
        "title": "Association of maternal prenatal copper concentration with gestational duration and preterm birth: a multicountry meta-analysis.",
        "abstract": "Copper Cu essential trace mineral regulating multiple action inflammation oxidative stress implicated risk preterm birth PTB study aimed determine association maternal Cu concentration pregnancy PTB risk gestational duration large multicohort study including diverse populations Maternal plasma serum sample 10449 singleton live birth obtained 18 geographically diverse study cohorts Maternal Cu concentration determined using inductively coupled plasma mass spectrometry association maternal Cu PTB gestational duration analyzed using logistic linear regression cohort estimate combined using metaanalysis Associations maternal Cu acutephase reactant APRs infection status analyzed 1239 sample Malawi cohort maternal prenatal Cu concentration study sample followed normal distribution mean 192 μgmL standard deviation 043 μgmL Cu concentration increased gestational age 20 wk randomeffect metaanalysis across 18 cohort revealed 1 μgmL increase maternal Cu concentration associated higher risk PTB odds ratio 130 95 confidence interval CI 108 157 shorter gestational duration 164 95 CI 056 273 Malawi cohort higher maternal Cu concentration concentration multiple APRs infection malaria HIV correlated associated greater risk PTB shorter gestational duration study support robust negative association maternal Cu gestational duration positive association risk PTB Cu concentration strongly correlated APRs infection status suggesting potential role inflammation pathway implicated mechanism PTB Therefore maternal Cu could used potential marker integrated inflammatory pathway pregnancy risk PTB",
        "mesh_terms": [
            "Pregnancy",
            "Female",
            "Humans",
            "Infant, Newborn",
            "Premature Birth",
            "Copper",
            "Gestational Age",
            "Live Birth",
            "Inflammation",
            "Risk Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37890672/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37875996",
        "title": "Co-designing community-based interventions to tackle antimicrobial resistance (AMR): what to include and why.",
        "abstract": "Antimicrobial resistance AMR social biological problem Although resistance antimicrobial natural phenomenon many human behavior increasing pressure microbe develop resistance resulting many commonly used treatment becoming ineffective behavior include unregulated use antimicrobial medicines pesticide agricultural chemicals disposal heavy metal pollutant environment humaninduced climatic change Addressing AMR thus call change behavior drive resistance Community engagement antimicrobial resistance CE4AMR international interdisciplinary network focused tackling behavioural driver AMR community level Since 2019 network worked within LowMiddle Income Countries LMICs predominantly within Southeast Asia tackle behavioral driver AMR mitigated bottomup solution championed local people commentary present seven Key Concepts identified across CE4AMR portfolio integral tackling AMR suggest used guide future intervention aimed addressing AMR via social participatory behaviorchange approaches",
        "mesh_terms": [
            "Humans",
            "Anti-Bacterial Agents",
            "Drug Resistance, Bacterial",
            "Anti-Infective Agents"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37875996/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37861484",
        "title": "Prevalence of Plasmodium species in Badr Governorate, Madinah Province, Saudi Arabia using microscopy and rapid diagnostic test.",
        "abstract": "Malaria infection still represents notable public health risk Saudi Arabia crosssectional study aimed determine prevalence Plasmodium specie among clinically suspected case presented Badr General Hospital healthcare facility selected region Badr Governorate Madinah Province Saudi Arabia January 2021 January 2022 total 493 suspected patient recruited Badr Governorate investigated malaria infection using CBFME rapid diagnostic test CareStart Malaria PfPAN HRP2pLDH Ag Combo rapid diagnostic tests result showed malaria infection 34 689 case among 493 suspected patient using microscopic examination reference test Moreover subject aged 31 40 year aged 51 60 year highest 50 lowest 882 percentage malaria cases Plasmodium vivax 1934 5588 higher P falciparum 1534 441 causative agent malaria cases majority malaria case 2934 809 among nonSaudi mainly Sudan 1534 441 Pakistan 534 147 Bangladesh 534 147 India 434 1176 whereas malaria case among Saudis 534 147 addition majority malaria case 3234 9411 among male subject 234 588 among females current study revealed malaria transmission still active Badr Governorate Madinah Province Saudi Arabia represents public health concern screening implement continuous epidemiological monitor status malaria infection Kingdom Saudi Arabia thus warranted improve controlling activity eradicate malaria endemicity country",
        "mesh_terms": [
            "Female",
            "Humans",
            "Male",
            "Saudi Arabia",
            "Rapid Diagnostic Tests",
            "Microscopy",
            "Prevalence",
            "Cross-Sectional Studies",
            "Sensitivity and Specificity",
            "Plasmodium",
            "Malaria",
            "Malaria, Falciparum",
            "Diagnostic Tests, Routine"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37861484/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37832986",
        "title": "Protocol for a randomised, multicentre, four-arm, double-blinded, placebo-controlled trial to assess the benefits and safety of iron supplementation with malaria chemoprevention to children in Malawi: IRMA trial.",
        "abstract": "Approximately 40 child aged 659 month worldwide anaemic Ironcontaining multiple micronutrient powder MNPs iron supplement syrupdrops used combat anaemia child different part world However evidence functional benefit iron supplementation child scarce potential risk remain poorly defined particularly concerning diarrhoea malaria trial aim determine if 1 efficacy iron supplement MNPs containing iron given malaria chemoprevention superior malaria chemoprevention alone 2 efficacy malaria chemoprevention alone superior placebo child cognitive development IRMA fourarm parallelgroup doubleblinded placebocontrolled tripledummy randomised trial Southern Malawi study recruit 2168 infant aged 6 months intervention period 6 month postintervention period 6 months Children randomised four arms 1 intervention placebo 2 malaria chemoprevention only 3 MNPs malaria chemoprevention 4 iron syrup malaria chemoprevention primary outcome cognitive development Cognitive Composite Score CogCS measured end 6 month intervention Secondary outcome include CogCS 6 month postintervention motor language behavioural development physical growth prevalence anaemia iron deficiency Safety outcome include incidence malaria infections prevalence malaria parasitaemia postintervention period trial approved National Health Sciences Research Committee 19012213 Malawi Human Research Ethics Committee WEHI 19012 Australia Written informed consent local language obtained participant conducting studyrelated procedure Results shared local community internationally academic policy stakeholders ACTRN12620000386932",
        "mesh_terms": [
            "Infant",
            "Humans",
            "Child",
            "Iron",
            "Malawi",
            "Malaria",
            "Anemia",
            "Dietary Supplements",
            "Chemoprevention",
            "Randomized Controlled Trials as Topic",
            "Multicenter Studies as Topic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37832986/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37824592",
        "title": "Clinical performance validation of the STANDARD G6PD test: A multi-country pooled analysis.",
        "abstract": "Screening G6PD deficiency inform disease management including malaria Treatment antimalarial drug primaquine tafenoquine guided pointofcare testing G6PD deficiency Data similar clinical study evaluating performance STANDARD G6PD Test SD Biosensor South Korea conducted Bangladesh Brazil Ethiopia India Thailand United Kingdom United States pooled Test performance assessed retrospective analysis capillary venous specimens study site used spectrophotometry reference G6PD testing either HemoCue complete blood count reference hemoglobin measurement sensitivity STANDARD G6PD Test using manufacturer threshold G6PD deficient intermediate case capillary specimen 4212 study participant 100 95 Confidence Interval CI 975100 G6PD deficient case 30 activity 77 95 CI 668854 female intermediate activity 3070 Specificity 981 95 CI 976985 928 95 CI 916939 G6PD deficient individual intermediate females respectively 20 G6PD intermediate female false normal results 12 activity level 60 reference assay negative predictive value female G6PD activity 60 996 95 CI 991998 capillary specimens Sensitivity among 396 P vivax malaria case 100 6921000 deficient intermediate cases Across full dataset 37 classified G6PD deficient intermediate resulted true normal cases Despite this 95 case would receive correct treatment primaquine 87 case would receive correct treatment tafenoquine true G6PD deficient case would treated inappropriately based result STANDARD G6PD Test STANDARD G6PD Test enables safe access drug contraindicated individual G6PD deficiency Operational consideration inform test uptake specific settings",
        "mesh_terms": [
            "Female",
            "Humans",
            "Primaquine",
            "Glucosephosphate Dehydrogenase Deficiency",
            "Retrospective Studies",
            "Antimalarials",
            "Malaria, Vivax"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37824592/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37759299",
        "title": "Epidemiology of malaria in Rohingya refugee camps in Bangladesh within 2017-2020.",
        "abstract": "Malaria cause significant morbidity mortality tropical subtropical regions particularly humanitarian emergency including refugee camp malaria endemic areas epidemiological investigation conducted malaria disease distribution risk factor worlds largest refugee settlement Rohingya refugee camp southeastern border area Bangladesh within 20172020 February 2017 March 2020 30460 febrile patient tested malaria using light microscopy rapid diagnostic tests selfpresenting symptomatic patient minority doortodoor malaria screening Diagnostic test done trained medical technologist upon advice concerned physician camps Test positivity rate  annual parasite incidence calculated compared using chisquared χ sup2sup test odds ratios overall average annual test positivity rate TPR 005 TPR highest people travelled forest previous 2 months 1360 Cases clustered among male adult aged 1560 years case among child five year pregnant woman death malaria study found malaria case among Rohingya refugee majority case imported hilly forested areas thus assumed act reservoir transmission",
        "mesh_terms": [
            "Pregnancy",
            "Adult",
            "Child",
            "Humans",
            "Female",
            "Male",
            "Child, Preschool",
            "Bangladesh",
            "Refugee Camps",
            "Malaria",
            "Risk Factors",
            "Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37759299/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37724615",
        "title": "Antimalarial drug discovery against malaria parasites through haplopine modification: An advanced computational approach.",
        "abstract": "widespread emergence antimalarial drug resistance created major threat public health Malaria lifethreatening infectious disease caused Plasmodium spp includes Apicoplast DNA polymerase Plasmodium falciparum cysteine protease falcipain2 component play critical role life cycle metabolic pathway involved breakdown erythrocyte hemoglobin host making promising target antimalarial drug design current study designed explore potential inhibitor haplopine derivative two target using silico approach total nine haplopine derivative used perform molecular docking result revealed Ligands 03 05 showed strong binding affinity compared control compound atovaquone Furthermore ligandprotein complex underwent molecular dynamic simulations result demonstrated complex maintained strong stability term RMSD root mean square deviation RMSF root mean square fluctuation Rg radius gyration 100 n simulation period Additionally PCA principal component analysis analysis dynamic crosscorrelation matrix showed positive outcome proteinligand complexes Moreover compound exhibited violation Lipinski rule ADMET absorption distribution metabolism excretion toxicity prediction yielded positive result without indicating toxicity Finally density functional theory DFT molecular electrostatic potential calculation conducted revealing mentioned derivative exhibited better stability outstanding performance Overall computational approach suggests haplopine derivative could serve potential source developing new effective antimalarial drug combat malaria However vitro vivo study might conducted determine actual effectiveness",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37724615/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37697804",
        "title": "Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 <i>Salmonella</i> Typhi genomes.",
        "abstract": "Global Typhoid Genomics Consortium established bring together typhoid research community aggregate analyse iSalmonella entericai serovar Typhi Typhi genomic data inform public health action analysis mark 22 year since publication first Typhi genome represents largest Typhi genome sequence collection date n13000 metaanalysis global genotype antimicrobial resistance AMR determinant extracted previously sequenced genome data analysed using consistent method implemented open analysis platform GenoTyphi Pathogenwatch Compared previous global snapshots data highlight genotype 431 H58 spread beyond Asia EasternSouthern Africa regions distinct genotype dominate independently evolved AMR Data gap remain many part world show potential travelassociated sequence provide informal sentinel surveillance locations data indicate ciprofloxacin nonsusceptibility 1 resistance determinant widespread across geography genotypes highlevel ciprofloxacin resistance ≥3 determinants reaching 20 prevalence South Asia Extensively drugresistant XDR typhoid become dominant Pakistan 70 2020 yet become established elsewhere Ceftriaxone resistance emerged eight nonXDR genotypes including ciprofloxacinresistant lineage 43121 India Azithromycin resistance mutation detected low prevalence South Asia including two common ciprofloxacinresistant genotypes consortiums aim encourage continued data sharing collaboration monitor emergence global spread AMR Typhi inform decisionmaking around introduction typhoid conjugate vaccine TCVs prevention control strategies specific funding awarded metaanalysis Coordinators supported fellowship European Union ZAD received funding European Unions Horizon 2020 research innovation programme Marie SklodowskaCurie grant agreement 845681 Wellcome Trust SB Wellcome Trust Senior Fellowship National Health Medical Research Council DJI supported NHMRC Investigator Grant GNT1195210",
        "mesh_terms": [
            "Humans",
            "Salmonella typhi",
            "Typhoid Fever",
            "Anti-Bacterial Agents",
            "Travel",
            "Drug Resistance, Bacterial",
            "Ciprofloxacin"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37697804/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37697263",
        "title": "Are we ready for a sustainable approach? A qualitative study of the readiness of the public health system to provide STI services to the key populations at risk of HIV in Bangladesh.",
        "abstract": "Bangladesh sexually transmitted infection STI service available population public health facilities However STI service key population KPs risk HIV need specifically designed approach predominantly administered KPs donorsupported service center operated nongovernment organization NGOs communitybased organisation CBOs However steady decline donor funding warrant sustainable transition STI service KPs public health facilities article aimed explore service availability readiness public health facility provide STI service KPs qualitative study explored service availability readiness public health facility three district Bangladesh adapting Service Availability Readiness Assessment tool conducted 34 indepth interviews11 focus group discussion KPs 29 keyinformant interview healthcare providers researchers programme implementers policy planners addition series direct observation public healthcare facilities Data analysed thematic analysis categorised relation building blocks study revealed public health system generally ready serve KPs need term providing quality STI services service delivery component crucial facet public health system ready provide STI service KPs Findings also indicated health workforce availability limited primary secondary healthcare layer adequate tertiary layer needed oriented providing culturally sensitised treatment Counseling essential component STI services neither ready available However health information system component partially ready although warrant systematic approach address challenges finding show public health facility yet fully ready render STI service KPs especially term service delivery human health resources Therefore integral mobilize community towards uptake public health services health system need prepared cater needs",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Public Health",
            "Qualitative Research",
            "Risk Factors",
            "HIV Infections"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37697263/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37692079",
        "title": "Provider adherence to clinical care recommendations for infants and children who died in seven low- and middle-income countries in the Child Health and Mortality Prevention Surveillance (CHAMPS) network.",
        "abstract": "childhood death globally considered preventable highquality clinical care includes adherence clinical care recommendations objective describe adherence World Health Organization recommendation management leading cause death among children conducted retrospective descriptive study examining clinical data child aged 159 month hospitalized died Child Health Mortality Prevention Surveillance CHAMPS catchment December 2016June 2021 Catchment area included Baliakandi Faridpur Bangladesh Kersa Haramaya Harar Ethiopia Kisumu Siaya Kenya Bamako Mali Manhiça Quelimane Mozambique Makeni Sierra Leone Soweto South Africa reviewed medical record died lower respiratory tract infections sepsis malnutrition malaria diarrheal disease determine proportion received recommended treatment compared adherence hospitalization duration CHAMPS enrolled 460 hospitalized child died leading cause median age 12 months 530 male Median hospital admission 31 h 510 n  127249 child died lower respiratory tract infection received supplemental oxygen Administration intravenous fluid sepsis 159 n  36226 supplemental feed malnutrition 140 n  18129 uncommon 514 n  55107 died malaria received antimalarials 80 child died diarrheal diseases 762 received intravenous fluids admitted ≥24 h commonly received antibiotic lower respiratory tract infection sepsis supplemental feed malnutrition intravenous fluid sepsis admitted 24 h Provision recommended clinical care leading cause death among young child suboptimal study needed understand reason deficit clinical care recommendation adherence Bill  Melinda Gates Foundation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37692079/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37661603",
        "title": "Knowledge and acceptance of malaria vaccine among parents of under-five children of malaria endemic areas in Bangladesh: A cross-sectional study.",
        "abstract": "Malaria exists endemic many country including Bangladesh malaria vaccine yet available here study aimed assess level knowledge acceptance malaria vaccination among parent child age five Bangladeshs malariaendemic area sociodemographic behavioural household factor associated acceptance knowledge malaria vaccine January March 2022 crosssectional study conducted five malariaendemic district Bangladesh involving 405 parent child age 5 met inclusion criteria Multiple logistic regression used analyze factor affecting parents acceptance knowledge malaria vaccination child five variables Majority 54 respondent mothers Almost half 49 respondent aged 26 35 year old around 90 rural areas small portion 20 participant housewife 46 completed primary education Overall 70 study participant reported would accept malaria vaccination independently onefourth 25 heard malaria vaccine 48 mentioned health professional source information Knowledge malaria vaccination found associated residence income family size Acceptance knowledge associated residence education occupation income family size multivariable analysis housing structure house wall house window knowledge malaria testing malaria diagnosed malaria associated knowledge acceptance getting vaccinated malaria present study highlight necessity creating awareness malaria vaccine epidemic area Bangladesh study offer crucial data develop policy novel malaria vaccine supporting adoption Bangladesh study based interviews interviewee recruited public representative malariaendemic area assist u building understanding knowledge acceptance malaria vaccine among parent underfive child Bangladesh",
        "mesh_terms": [
            "Female",
            "Humans",
            "Child",
            "Adult",
            "Malaria Vaccines",
            "Cross-Sectional Studies",
            "Bangladesh",
            "Vaccination",
            "Parents",
            "Malaria",
            "Health Knowledge, Attitudes, Practice"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37661603/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37500334",
        "title": "Bangladesh in the era of malaria elimination.",
        "abstract": "Bangladesh dramatically reduced malaria 93 2008 2020 strategy districtwise phased elimination however last district targeted elimination include remote forested region present several challenge prevention detection treatment malaria district border Myanmar harbor Plasmodium falciparum malaria parasite resistant artemisinins key drug used artemisininbased combination therapy ACTs vital control programs Challenges monitoring emergence artemisinin resistance AR tracking parasite reservoirs change vector behavior response insecticides well environmental host factor including migration Forcibly Displaced Myanmar Nationals FDMNs may pose added hazard final phase eliminating malaria Bangladesh",
        "mesh_terms": [
            "Humans",
            "Plasmodium falciparum",
            "Bangladesh",
            "Drug Resistance",
            "Malaria",
            "Malaria, Falciparum",
            "Antimalarials"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37500334/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37494044",
        "title": "Causes of Death Among Infants and Children in the Child Health and Mortality Prevention Surveillance (CHAMPS) Network.",
        "abstract": "number death child younger 5 year steadily decreasing worldwide 17 million annual death 1970s estimated 53 million 2019 with 28 million death occurring aged 159 month 53 death child aged 5 years detailed characterization childhood death could inform intervention improve child survival describe cause postneonatal child death across 7 mortality surveillance sentinel site Africa Asia Child Health Mortality Prevention Surveillance CHAMPS Network conduct childhood mortality surveillance subSaharan Africa South Asia using innovative postmortem minimally invasive tissue sampling MITS crosssectional study MITS conducted deceased child aged 1 59 month 7 site subSaharan Africa South Asia December 3 2016 December 3 2020 Data analysis conducted October November 2021 expert panel attributed underlying intermediate immediate condition chain event leading death based histopathologic analysis microbiological diagnostics clinical data verbal autopsies study MITS performed 632 deceased child mean SD age death 13 03 years 342 541 male 6 common underlying cause death malnutrition 104 165 HIV 75 119 malaria 71 112 congenital birth defect 64 101 lower respiratory tract infection LRTIs 53 84 diarrheal disease 46 72 considering immediate cause only sepsis 191 367 LRTI 129 248 2 dominant causes infection present causal chain 549 632 death 869 pathogen frequently contributing infectious death included Klebsiella pneumoniae 155 549 infectious death 282 127 819 considered nosocomial Plasmodium falciparum 122 549 222 Streptococcus pneumoniae 109 549 199 organisms cytomegalovirus 57 104 Acinetobacter baumannii 39 71 35 39 897 considered nosocomial also played important roles top underlying cause death median number condition chain event leading death 3 malnutrition 3 HIV 1 malaria 3 congenital birth defects 1 LRTI Expert panel considered 494 632 death 782 preventable 26 632 death 41 preventable certain conditions crosssectional study investigating cause child mortality CHAMPS Network result indicate that highmortality settings infectious disease continue cause death infant children often conjunction malnutrition result also highlight opportunity action prevent death reveal common interaction various cause path toward death",
        "mesh_terms": [
            "Infant",
            "Child",
            "Humans",
            "Male",
            "Female",
            "Child Mortality",
            "Cause of Death",
            "Child Health",
            "Cross-Sectional Studies",
            "Africa South of the Sahara",
            "Malnutrition",
            "Malaria",
            "Cross Infection",
            "HIV Infections"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37494044/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37473798",
        "title": "Antiplasmodial and interferon-gamma-modulating activities of the aqueous extract of stone breaker (Phyllanthus niruri Linn.) in malaria infection.",
        "abstract": "Plasmodium falciparum parasite primary cause malaria across Africa problem drug resistance malaria ever growing novel therapeutic strategy need developed particularly targeting parasite also host hostpathogen interaction Previous study shown development cerebral malaria CM related dysregulation immune system murine malaria model experimental cerebral malaria involves complex interaction event interferongamma seems unifying factor Therefore antiplasmodial activity targeting parasite immunomodulatory strategy reduce overall host inflammation IFNγ focus could delay CM onset prove beneficial malaria infection therapy Phyllanthus niruri used treat fever symptom malaria Nigeria mode action antimalarial remedy exhaustively investigated study therefore examined aqueous extract P niruri PE antiplasmodial activity vitro using Plasmodium falciparum HB3 strain Furthermore vivo murine malaria model using Plasmodium berghei ANKA strain used investigate antimalarial effects showed PE multiple antimalarial effects including antiparasitic host immunomodulatory activities Coculture P falciparum PE phytoconstituents drastically reduced parasite number PE also decreased parasitemia increased survival infected mice also observed integrity bloodbrain barrier maintained PEtreated mice result confirmed PE showed moderate antiplasmodial activity vivo murine malaria model using P berghei ANKA experimental cerebral malaria revealed PE suppressed parasite growth modulate production interferongamma finding demonstrate PE affect malaria progression targeting parasite host cells",
        "mesh_terms": [
            "Mice",
            "Animals",
            "Antimalarials",
            "Malaria, Cerebral",
            "Interferon-gamma",
            "Phyllanthus",
            "Plant Extracts",
            "Malaria, Falciparum",
            "Plasmodium falciparum",
            "Nigeria",
            "Plasmodium berghei"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37473798/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37367359",
        "title": "Effects of Temperature and Nutrition during the Larval Period on Life History Traits in an Invasive Malaria Vector <i>Anopheles stephensi</i>.",
        "abstract": "iAnopheles stephensii Asian Middle Eastern malaria vector recently spread African continent needed measure malaria parasite infection iAi istephensii influenced environmental factor predict expansion new environment Effects temperature food condition larval period larval mortality larval period female wing size egg production egg size adult longevity malaria infection rate studied using laboratory strain Larval survival female wing size generally reduced reared higher temperature low food supply larval period Egg production significantly affected temperature larval period Egg size generally smaller female reared higher temperature larval period infection rate mosquito fed blood malariainfected mouse affected rearing temperature food condition larval period Higher temperature may reduce infection iAi istephensii however larger individual still infective suggest routinely recording body size adult field survey effective finding productive larval breeding site predicting malaria risk",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37367359/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37363565",
        "title": "Dreadful infectious disease outbreaks threaten flood-ravaged pakistan: short communication.",
        "abstract": "rise incidence waterborne communicable illnesses viral outbreak Pakistan follows period heavy rainfall Due climate change flood drought devastating effect human health facilitating spread infectious illness including cholera malaria typhoid dengue fever viral hepatitis A Food instability starvation malnutrition lack potable water indirect effect flooding health Recently one worst flood history devastated Pakistan affecting 333 million people along significant portion nation submerged Malaria dengue fever ailment rise Pakistan threatening overwhelm countrys healthcare infrastructure urgent need preventative measure Pakistan cope dreadful outbreaks",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37363565/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37280591",
        "title": "Composition of Anopheles species and bionomic characteristics over the peak malaria transmission season in Bandarban, Bangladesh.",
        "abstract": "Joint effort government nongovernment organization helped reduce malaria Bangladesh set country clear path eventual malaria elimination However achieving goal would challenging without comprehensive understanding vector bionomics Targeted capturing Anopheles mosquito rainy season utilizing specific sampling methods including human landing catch HLCs CDClight trap CDCLTs pyrethrum spray catch PSCs aimed characterize entomological driver transmission four site Bandarban Bangladesh Molecular characterization subset 4637 mosquito demonstrated presence least 17 specie whose capture rate representative rainy season Species composition bionomic trait vary site Anopheles maculatus highest landing rate HLCs Anopheles vagus highest capture rate CDCLTs Interestingly Anopheles specie composition capture rate varied significantly p  005 An vagus HLCs oftenused proxyCDCLTs suggesting impact downstream analysis CDCLTs capture rate demonstrated differing composition indoor outdoor biting rates example Anopheles nigerrimus Anopheles nivipes endophagic HLCs exophagic CDCLTs use cowbaited CDCLT also demonstrated significantly different result compared humanbaited CDCLT considering high degree anthropophily species exception zoophily indoor resting An vagus demonstrated anthropophily high resting rate indoorspointing specie possible primary vector site diverse Anopheles fauna Bandarban confirmed molecular methods highlighting potential impact sampling techniques Given complexity local ecosystem better understanding mosquito behaviour ecology required achieve goal malaria elimination Bangladesh",
        "mesh_terms": [
            "Animals",
            "Female",
            "Cattle",
            "Humans",
            "Anopheles",
            "Ecosystem",
            "Bangladesh",
            "Seasons",
            "Mosquito Vectors",
            "Malaria",
            "Ecology"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37280591/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37224836",
        "title": "Lancet Commission on synergies between universal health coverage, health security, and health promotion.",
        "abstract": "",
        "mesh_terms": [
            "Humans",
            "Universal Health Insurance",
            "Health Services Accessibility",
            "Health Promotion"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37224836/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37215766",
        "title": "Mosquito repellent fabric: Development and characterization of peppermint and garlic mixture finish on knitted fabric to examine mosquito repellency.",
        "abstract": "Mosquitorepellent textile part protective textile help protection specie prone cause disease like malaria dengue fever study explored possibility natural extract alcoholic peppermint leaves stems garlic clove use mosquitorepellent finish material knit fabric Accordingly different concentration 5 15 25 35 PGE Peppermint Garlic Extract solution prepared applied developed fabric using exhaust dyeing process assess mosquito Aedes Aegypti L repellency performance Following World Health Organization standard cone bioassay selfmodified cage technique literature survey mosquito protection repellency test performed characterization finding revealed PGEtreated fabric sample C 25 PGE 35 PGE highest mosquito mortality 5000 7667 respectively repellency 786 856 respectively rates Moreover study evaluated prepared PGE formulations shelflife performance colorfastness property PGEtreated fabrics including impact washing cycle treated fabrics fungal growth fabric showed excellent colorfastness properties However efficacy treated fabric decreased increasing number washes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37215766/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37142319",
        "title": "Patient adherence to tuberculosis treatment in the Indian subcontinent: systematic review and meta-synthesis of qualitative research.",
        "abstract": "well patient adhere tuberculosis TB treatment influence recovery development drug resistance influence adherence multiple often competing synthesised qualitative study setting Indian subcontinent understand dimension dynamic involved help inform service provision Qualitative synthesis comprising inductive coding thematic analysis forming conceptual framework Medline OVID Embase OVID CINAHL EBSCOHost PsycINFO EBSCOHost Web Science Core Collection Cochrane Library Epistemonikos database searched 26 March 2020 study published since 1 January 2000 included report English Indian subcontinent used qualitative mixedmethodology design reported finding around adherence TB treatment Full text meeting eligibility sampled based thickness the richness qualitative data reported Two reviewer used standardised method screen abstract code Included study assessed reliability quality using standard tool Qualitative synthesis performed inductive coding thematic analysis developing conceptual framework 1729 abstract screened initial search 59 shortlisted fulltext review Twentyfour study qualified thick included synthesis Studies set India 12 Pakistan 6 Nepal 3 Bangladesh 1 two country 2 24 studies one included people taking TB treatment 1 study included healthcare providers 17 included healthcare workers community member bothWe identified three themes 1 personal influence people TB include interconnection social role family unit priority daytoday living experience date disease 2 adherence profoundly influenced individual healthcare provider interact patient treatment address needs 3 adherence influenced across community structural social economic cultural factor related treatment Staff TB programme require understanding various competing influence individual undergoing treatment Programmes need flexible peoplecentred approach service provision order achieve adherence thus improve treatment outcomes CRD42020171409",
        "mesh_terms": [
            "Humans",
            "Health Personnel",
            "Patient Compliance",
            "Qualitative Research",
            "Reproducibility of Results",
            "Tuberculosis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37142319/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37076740",
        "title": "Optimal Interruption of P. vivax Malaria Transmission Using Mass Drug Administration.",
        "abstract": "Plasmodium vivax geographically widespread malariacausing parasite resulting significant associated global morbidity mortality One factor driving widespread phenomenon ability parasite remain dormant liver Known hypnozoites reside liver following initial exposure activating later cause infections referred relapses around 7996 infection attributed relapse activating hypnozoites expect highly impactful apply treatment target hypnozoite reservoir ie collection dormant parasites eliminate P vivax Treatment radical cure example tafenoquine primaquine target hypnozoite reservoir potential tool control andor eliminate P vivax developed deterministic multiscale mathematical model system integrodifferential equation capture complex dynamic P vivax hypnozoites effect hypnozoite relapse disease transmission Here use multiscale model study anticipated effect radical cure treatment administered via mass drug administration MDA program implement multiple round MDA fixed interval rounds starting different steadystate disease prevalences construct optimisation model three different objective function motivated public health basis obtain optimal MDA interval also incorporate mosquito seasonality model study effect optimal treatment regime find effect MDA intervention temporary depends preintervention disease prevalence and choice model parameters well number MDA round consideration optimal interval MDA round also depends objective combinations expected intervention outcomes find radical cure alone may enough lead P vivax elimination mathematical model and choice model parameters since prevalence infection eventually return preMDA levels",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Malaria, Vivax",
            "Antimalarials",
            "Mass Drug Administration",
            "Models, Biological",
            "Mathematical Concepts",
            "Malaria",
            "Recurrence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37076740/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37033548",
        "title": "National Malaria Control Program in Bangladesh: 2007-2010.",
        "abstract": "Malaria lifethreatening disease caused plasmodium parasite transmitted people bite infected mosquitoes elsewhere disease also major public health problem Bangladesh independence dichlorodiphenyltrichloroethane DDT use banned 1985 number malaria case began increase control program inadequate funds especially malariaendemic areas thus malaria case started epidemic 1990s global fund supporting National Malaria Control Program NMCP Bangladesh since approval round 6 malaria proposal 2006 study aim review NMCP change burden malaria Bangladesh 2007 2010 descriptive retrospective study based secondary malaria surveillance data cases deaths 13 malariaendemic districts especially five selected districts Chittagong Coxs Bazar Rangamati Sylhet Mymensingh descriptive analysis carried establish incidence mortality rate 2007 2010 total 264293 confirmed malaria case notified 13 malariaendemic districts 50 affected population age group ≥15 year 557 Males higher risk contracting malaria females accounting 535 confirmed case compared 465 females Among affected population iPlasmodium falciparumi caused 856 total incidence Rangamati highest incidence rate among five districts Although incidence high death declining 2007 228 2010 37 finding show incidence still high mortality decreasing therefore said NMCP functioning However fully achieve goal eliminating malaria NMCP requires effort develop new strategy maintain highquality surveillance reporting system",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37033548/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "36942761",
        "title": "Insecticide resistance compromises the control of Aedes aegypti in Bangladesh.",
        "abstract": "effective drug widely available vaccines dengue control Bangladesh dependent targeting primary vector Aedes aegypti insecticide larval source management Despite interventions dengue burden increasing Bangladesh country experienced worst outbreak 2019 101 354 hospitalized cases may partially facilitated presence intense insecticide resistance vector populations Here describe intensity mechanism resistance insecticide commonly deployed Ae aegypti Dhaka Bangladesh Dhaka Ae aegypti colony exhibited highintensity resistance pyrethroids Using CDC bottle assays recorded 224 mortality recorded 24 h permethrin 4894 mortality deltamethrin 10× diagnostic dose Bioassays conducted using insecticidesynergist combination suggested metabolic mechanism contributing pyrethroid resistance specifically multifunction oxidases esterases glutathione Stransferases addition kdr allele detected high frequency 7898 homozygote V1016G mutation large proportion ≤ 74 freeflying resting mosquito Dhaka colony survived exposure standard application pyrethroid aerosol experimental freeflight room Although exposure affected immediate hostseeking behavior Ae aegypti effect transient surviving mosquitoes intense resistance characterized study likely compromising operational effectiveness pyrethroids Ae aegypti Dhaka Switching alternative chemical class may offer mediumterm solution ultimately sustainable effective approach controlling dengue vector required © 2023 Authors Pest Management Science published John Wiley  Sons Ltd behalf Society Chemical Industry",
        "mesh_terms": [
            "Animals",
            "Insecticides",
            "Insecticide Resistance",
            "Aedes",
            "Bangladesh",
            "Mosquito Vectors",
            "Pyrethrins",
            "Dengue"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36942761/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "36941291",
        "title": "Malaria hotspots and climate change trends in the hyper-endemic malaria settings of Mizoram along the India-Bangladesh borders.",
        "abstract": "India made tremendous progress reducing malaria mortality morbidity last decade Mizoram State NorthEast India one malariaendemic region malaria transmission continued remain high Mizoram share international border Bangladesh Myanmar malaria control region critical malaria elimination effort three countries identifying hotspot targeted intervention malaria data 385 public health subcenters across Mizoram analyzed Geographic Information System Almost subcenters reporting high Annual Parasite Index  10 located Mizorams district border Bangladesh GetisOrd Gsubisub statistic show subcenters located along Bangladesh border Lawngtlai Lunglei district malaria hotspots hotspot also extended Mamit Siaha districts especially along border Lawngtlai Lunglei Analysis terrain climatic land useland cover datasets obtained Global Modelling Assimilation Office satellite image show Mizorams western part Lawngtlai Lunglei Mamit districts experience similar topographic climatic condition bordering Rangamati district Chittagong division Bangladesh Climatic trend region 1981 2021 estimated MannKendall test Sens slope estimates show increasing trend minimum temperature relative humidity rainfall associated shift climatic pattern temperate tropical monsoon could facilitate malaria transmission quasiPoisson regression model estimate strong association p  0001 total malaria cases temperature range elevation KruskalWallis H test show statistically significant association malaria case forest class p  0001 regional coordination strategic plan required eliminate malaria hyperendemic malaria region NorthEast India",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Climate Change",
            "Malaria",
            "India",
            "Public Health"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36941291/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "36864926",
        "title": "Pf7: an open dataset of <i>Plasmodium falciparum</i> genome variation in 20,000 worldwide samples.",
        "abstract": "describe MalariaGEN Pf7 data resource seventh release iPlasmodium falciparumi genome variation data MalariaGEN network comprises 20000 sample 82 partner study 33 countries including several malaria endemic region previously underrepresented first time include dried blood spot sample sequenced selective whole genome amplification necessitating new method genotype copy number variations identify large number newly emerging icrti mutation part Southeast Asia show example heterogeneity pattern drug resistance within Africa within Indian subcontinent describe profile variation Cterminal icspi gene relate sequence used RTSS R21 malaria vaccines Pf7 provides highquality data genotype call 6 million SNPs short indels analysis large deletion cause failure rapid diagnostic tests systematic characterisation six major drug resistance loci freely downloaded MalariaGEN website",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36864926/",
        "source_type": "Bangladesh-specific"
    }
]